Michael F Green

Title(s)Professor-in-Residence, Psychiatry and Biobehavioral Sciences
SchoolMedicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Oberlin College, Oberlin, OHBA1979Psychobiology
    Cornell University, Ithaca, NYPhD1984Neuropsychology

    Collapse Overview 
    Collapse Websites

    Collapse Research 
    Collapse Research Activities and Funding
    Enhancing Community Integration for Homeless Veterans
    NIH I50RX003437Oct 1, 2020 - Sep 30, 2025
    Role: Principal Investigator
    Feasibility of Mobile Technology-Based Assessments of Community Reintegration in Homeless Veterans
    NIH I21RX003165Oct 1, 2019 - Sep 30, 2021
    Role: Principal Investigator
    The Determinants of Social Disconnectedness: A Spectrum from the General Community to Severe Mental Illness
    NIH R01MH110470Sep 1, 2016 - Jun 30, 2021
    Role: Principal Investigator
    Enhancing Community Integration for Homeless Veterans
    NIH I50RX001875May 1, 2015 - Sep 30, 2020
    Role: Principal Investigator
    Homeless Veterans with Mental Illness: Predicting and Enhancing Recovery
    NIH I01RX001116Mar 1, 2014 - Feb 28, 2018
    Role: Principal Investigator
    Visual tuning and performance in schizophrenia and bipolar disorder
    NIH R01MH095878Jun 12, 2012 - Feb 28, 2019
    Role: Principal Investigator
    Social Processing Systems in Veterans with Schizophrenia: Identifying Deficits in Brain Activation and Network Organization
    NIH I01CX000230Oct 1, 2010 - Dec 31, 2021
    Role: Principal Investigator
    Social Cognition and Functioning in Schizophrenia
    NIH R01MH087618Aug 1, 2010 - Feb 28, 2015
    Role: Principal Investigator
    Social Cognition and Functioning in Bipolar Disorder
    NIH RC1MH089634Sep 30, 2009 - Aug 31, 2011
    Role: Principal Investigator
    3/6-The Genetics of Endophenotypes and Schizophrenia
    NIH R01MH065707May 1, 2003 - Jan 31, 2015
    Role: Principal Investigator
    Early Visual Processing in Schizophrenia
    NIH R01MH043292Aug 1, 1988 - Apr 30, 2012
    Role: Principal Investigator
    EARLY VISUAL PROCESSING IN SCHIZOPHRENIA
    NIH R29MH043292Aug 1, 1988 - Jul 31, 1994
    Role: Principal Investigator
    NEUROBEHAVIORAL AND ATTENTIONAL FACTORS IN SCHIZOPHRENIA
    NIH R03MH042344Sep 25, 1986 - Aug 31, 1987
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Approaches to Studying and Improving Social Motivation in Schizophrenia. Schizophr Bull. 2023 09 07; 49(5):1108-1111. Catalano LT, Green MF. PMID: 37410026; PMCID: PMC10483455.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Social Motivation in Schizophrenia: What's Effort Got to Do With It? Schizophr Bull. 2023 09 07; 49(5):1127-1137. Catalano LT, Green MF. PMID: 37354079; PMCID: PMC10483329.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Financial health and psychiatric symptoms among veterans with psychosis or recent homelessness during the COVID-19 pandemic. Psychol Serv. 2023 Jul 06. Tsai J, McCleery A, Wynn JK, Green MF. PMID: 37410791; PMCID: PMC10770285.
      View in: PubMed   Mentions:    Fields:    
    4. A Bayesian Network Approach to Social and Nonsocial Cognition in Schizophrenia: Are Some Domains More Fundamental than Others? Schizophr Bull. 2023 07 04; 49(4):997-1006. Abplanalp SJ, Lee J, Horan WP, Kern RS, Penn DL, Green MF. PMID: 36869810; PMCID: PMC10318874.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. Neurobehavioral indices of gaze perception are associated with social cognition across schizophrenia patients and healthy controls. J Psychopathol Clin Sci. 2023 Aug; 132(6):733-748. Blain SD, Taylor SF, Rutherford SE, Lasagna CA, Yao B, Angstadt M, Green MF, Johnson TD, Peltier S, Diwadkar VA, Tso IF. PMID: 37384487; PMCID: PMC10513759.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. The impact of psychological strengths on Veteran populations' mental health trajectories during the COVID-19 pandemic. Soc Psychiatry Psychiatr Epidemiol. 2024 Jan; 59(1):111-120. McCleery A, Wynn JK, Novacek DM, Reavis EA, Senturk D, Sugar CA, Tsai J, Green MF. PMID: 37314492; PMCID: PMC10719422.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    7. Neuroimaging of social motivation during winning and losing: Associations with social anhedonia across the psychosis spectrum. Neuropsychologia. 2023 09 09; 188:108621. Jimenez AM, Clayson PE, Hasratian AS, Lee J, Reavis EA, Wynn JK, Green MF, Horan WP. PMID: 37321406; PMCID: PMC10527321.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Unconditional Cash Transfers and Association With Clinical Outcomes Among U.S. Veterans With Psychosis or Recent Homelessness. Psychiatr Serv. 2023 11 01; 74(11):1123-1131. Tsai J, McCleery A, Wynn JK, Green MF. PMID: 37161346.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    9. Neurophysiological indices of face processing in people with psychosis and their siblings: An event-related potential study. Eur J Neurosci. 2023 May 09. Wynn JK, Clayson PE, Green MF, Jimenez A, Lee J, Reavis EA, Horan WP. PMID: 37160716; PMCID: PMC10632544.
      View in: PubMed   Mentions:    Fields:    
    10. Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden. Am J Psychiatry. 2023 07 01; 180(7):519-523. Joshi YB, Molina JL, Braff DL, Green MF, Gur RC, Gur RE, Nuechterlein KH, Stone WS, Greenwood TA, Lazzeroni LC, Radant AD, Silverman JM, Sprock J, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Swerdlow NR, Light GA. PMID: 37038743.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. A Novel Psychosocial Intervention for Motivational Negative Symptoms in Schizophrenia: Combined Motivational Interviewing and CBT. Am J Psychiatry. 2023 05 01; 180(5):367-376. Reddy LF, Glynn SM, McGovern JE, Sugar CA, Reavis EA, Green MF. PMID: 36891649.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    12. The MATRICS Consensus Cognitive Battery: An Update. Curr Top Behav Neurosci. 2023; 63:1-18. Nuechterlein KH, Green MF, Kern RS. PMID: 36306054.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. An Update on Treatment of Cognitive Impairment Associated with Schizophrenia. Curr Top Behav Neurosci. 2023; 63:407-436. Horan WP, Catalano LT, Green MF. PMID: 35915386.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Reorganization of the functional connectome from rest to a visual perception task in schizophrenia and bipolar disorder. Psychiatry Res Neuroimaging. 2022 12; 327:111556. Riedel P, Lee J, Watson CG, Jimenez AM, Reavis EA, Green MF. PMID: 36327867; PMCID: PMC10611423.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Understanding Connections and Boundaries Between Positive Symptoms, Negative Symptoms, and Role Functioning Among Individuals With Schizophrenia: A Network Psychometric Approach. JAMA Psychiatry. 2022 10 01; 79(10):1014-1022. Abplanalp SJ, Braff DL, Light GA, Nuechterlein KH, Green MF, Consortium on the Genetics of Schizophrenia-2. PMID: 35976655; PMCID: PMC9386606.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. Aberrant reward processing to positive versus negative outcomes across psychotic disorders. J Psychiatr Res. 2022 12; 156:1-7. Le TP, Green MF, Lee J, Clayson PE, Jimenez AM, Reavis EA, Wynn JK, Horan WP. PMID: 36201975; PMCID: PMC10163955.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. The flickering spotlight of visual attention: Characterizing abnormal object-based attention in schizophrenia. Schizophr Res. 2022 10; 248:151-157. Reavis EA, Wynn JK, Green MF. PMID: 36063606; PMCID: PMC10362949.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. The impact of the COVID-19 pandemic on mental health and functional outcomes in Veterans with psychosis or recent homelessness: A 15-month longitudinal study. PLoS One. 2022; 17(8):e0273579. Wynn JK, McCleery A, Novacek DM, Reavis EA, Senturk D, Sugar CA, Tsai J, Green MF. PMID: 36001641; PMCID: PMC9401176.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    19. Intact differentiation of responses to socially-relevant emotional stimuli across psychotic disorders: An event-related potential (ERP) study. Schizophr Res. 2022 08; 246:250-257. Clayson PE, Wynn JK, Jimenez AM, Reavis EA, Lee J, Green MF, Horan WP. PMID: 35843157; PMCID: PMC10413986.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. N-Acetylcysteine effects on glutathione and glutamate in schizophrenia: A preliminary MRS study. Psychiatry Res Neuroimaging. 2022 Sep; 325:111515. Yang YS, Maddock RJ, Zhang H, Lee J, Hellemann G, Marder SR, Green MF. PMID: 35839558.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Racial differences in the psychosocial response to the COVID-19 pandemic in veterans with psychosis or recent homelessness. Am J Orthopsychiatry. 2022; 92(5):590-598. Novacek DM, Wynn JK, McCleery A, Reavis EA, Senturk D, Sugar CA, Tsai J, Green MF. PMID: 35737567; PMCID: PMC9958263.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    22. Reduced neural activity when anticipating social versus nonsocial rewards in schizophrenia: Preliminary evidence from an ERP study. Schizophr Res. 2022 08; 246:7-16. Catalano LT, Wynn JK, Green MF, Gold JM. PMID: 35696860.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    23. Acceptability of a mobile sensing application to characterize community integration among homeless-experienced veterans. J Community Psychol. 2023 01; 51(1):7-16. Harris T, Gabrielian S, Ilagan B, Olsen MK, Green MF. PMID: 35567522.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Symptom Structure in Schizophrenia: Implications of Latent Variable Modeling vs Network Analysis. Schizophr Bull. 2022 05 07; 48(3):538-543. Abplanalp SJ, Green MF. PMID: 35243503; PMCID: PMC9077428.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. Social cognition and social problem solving skills training to improve job functioning and tenure in veterans with psychotic disorders. Psychiatr Rehabil J. 2022 Sep; 45(3):291-298. Kern RS, Reddy LF, Horan WP, Glynn SM, Stigers PJ, Sugar CA, Green MF. PMID: 35404648.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022 04; 604(7906):502-508. Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, Bryois J, Chen CY, Dennison CA, Hall LS, Lam M, Watanabe K, Frei O, Ge T, Harwood JC, Koopmans F, Magnusson S, Richards AL, Sidorenko J, Wu Y, Zeng J, Grove J, Kim M, Li Z, Voloudakis G, Zhang W, Adams M, Agartz I, Atkinson EG, Agerbo E, Al Eissa M, Albus M, Alexander M, Alizadeh BZ, Alptekin K, Als TD, Amin F, Arolt V, Arrojo M, Athanasiu L, Azevedo MH, Bacanu SA, Bass NJ, Begemann M, Belliveau RA, Bene J, Benyamin B, Bergen SE, Blasi G, Bobes J, Bonassi S, Braun A, Bressan RA, Bromet EJ, Bruggeman R, Buckley PF, Buckner RL, Bybjerg-Grauholm J, Cahn W, Cairns MJ, Calkins ME, Carr VJ, Castle D, Catts SV, Chambert KD, Chan RCK, Chaumette B, Cheng W, Cheung EFC, Chong SA, Cohen D, Consoli A, Cordeiro Q, Costas J, Curtis C, Davidson M, Davis KL, de Haan L, Degenhardt F, DeLisi LE, Demontis D, Dickerson F, Dikeos D, Dinan T, Djurovic S, Duan J, Ducci G, Dudbridge F, Eriksson JG, Fañanás L, Faraone SV, Fiorentino A, Forstner A, Frank J, Freimer NB, Fromer M, Frustaci A, Gadelha A, Genovese G, Gershon ES, Giannitelli M, Giegling I, Giusti-Rodríguez P, Godard S, Goldstein JI, González Peñas J, González-Pinto A, Gopal S, Gratten J, Green MF, Greenwood TA, Guillin O, Gülöksüz S, Gur RE, Gur RC, Gutiérrez B, Hahn E, Hakonarson H, Haroutunian V, Hartmann AM, Harvey C, Hayward C, Henskens FA, Herms S, Hoffmann P, Howrigan DP, Ikeda M, Iyegbe C, Joa I, Julià A, Kähler AK, Kam-Thong T, Kamatani Y, Karachanak-Yankova S, Kebir O, Keller MC, Kelly BJ, Khrunin A, Kim SW, Klovins J, Kondratiev N, Konte B, Kraft J, Kubo M, Kucinskas V, Kucinskiene ZA, Kusumawardhani A, Kuzelova-Ptackova H, Landi S, Lazzeroni LC, Lee PH, Legge SE, Lehrer DS, Lencer R, Lerer B, Li M, Lieberman J, Light GA, Limborska S, Liu CM, Lönnqvist J, Loughland CM, Lubinski J, Luykx JJ, Lynham A, Macek M, Mackinnon A, Magnusson PKE, Maher BS, Maier W, Malaspina D, Mallet J, Marder SR, Marsal S, Martin AR, Martorell L, Mattheisen M, McCarley RW, McDonald C, McGrath JJ, Medeiros H, Meier S, Melegh B, Melle I, Mesholam-Gately RI, Metspalu A, Michie PT, Milani L, Milanova V, Mitjans M, Molden E, Molina E, Molto MD, Mondelli V, Moreno C, Morley CP, Muntané G, Murphy KC, Myin-Germeys I, Nenadic I, Nestadt G, Nikitina-Zake L, Noto C, Nuechterlein KH, O'Brien NL, O'Neill FA, Oh SY, Olincy A, Ota VK, Pantelis C, Papadimitriou GN, Parellada M, Paunio T, Pellegrino R, Periyasamy S, Perkins DO, Pfuhlmann B, Pietiläinen O, Pimm J, Porteous D, Powell J, Quattrone D, Quested D, Radant AD, Rampino A, Rapaport MH, Rautanen A, Reichenberg A, Roe C, Roffman JL, Roth J, Rothermundt M, Rutten BPF, Saker-Delye S, Salomaa V, Sanjuan J, Santoro ML, Savitz A, Schall U, Scott RJ, Seidman LJ, Sharp SI, Shi J, Siever LJ, Sigurdsson E, Sim K, Skarabis N, Slominsky P, So HC, Sobell JL, Söderman E, Stain HJ, Steen NE, Steixner-Kumar AA, Stögmann E, Stone WS, Straub RE, Streit F, Strengman E, Stroup TS, Subramaniam M, Sugar CA, Suvisaari J, Svrakic DM, Swerdlow NR, Szatkiewicz JP, Ta TMT, Takahashi A, Terao C, Thibaut F, Toncheva D, Tooney PA, Torretta S, Tosato S, Tura GB, Turetsky BI, Üçok A, Vaaler A, van Amelsvoort T, van Winkel R, Veijola J, Waddington J, Walter H, Waterreus A, Webb BT, Weiser M, Williams NM, Witt SH, Wormley BK, Wu JQ, Xu Z, Yolken R, Zai CC, Zhou W, Zhu F, Zimprich F, Atbasoglu EC, Ayub M, Benner C, Bertolino A, Black DW, Bray NJ, Breen G, Buccola NG, Byerley WF, Chen WJ, Cloninger CR, Crespo-Facorro B, et al. PMID: 35396580; PMCID: PMC9392466.
      View in: PubMed   Mentions: 460     Fields:    Translation:Humans
    27. Examining racial differences in community integration between black and white homeless veterans. Psychiatry Res. 2022 02; 308:114385. Novacek DM, Wynn JK, Gabrielian S, Glynn SM, Hellemann G, Horan WP, Kern RS, Lee J, Marder SR, Sugar C, Green MF. PMID: 34999292.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. Factors associated with recovery from homelessness among veterans in permanent supportive housing. J Community Psychol. 2022 07; 50(5):2144-2162. Gabrielian S, Koosis ER, Cohenmehr J, Hellemann G, Tuepker A, Green MF, Vazzano JK, Young AS. PMID: 34862803.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. The effect of sex on social cognition and functioning in schizophrenia. NPJ Schizophr. 2021 Dec 01; 7(1):57. Ferrer-Quintero M, Green MF, Horan WP, Penn DL, Kern RS, Lee J. PMID: 34853324; PMCID: PMC8636592.
      View in: PubMed   Mentions: 9  
    30. Socioeconomic challenges during the COVID-19 pandemic for Veterans with psychosis or recent homelessness. Health Soc Care Community. 2022 09; 30(5):e2169-e2178. McCleery A, Wynn JK, Novacek D, Reavis EA, Tsai J, Green MF. PMID: 34806259; PMCID: PMC9011530.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    31. A comparison of stages of attention for social and nonsocial stimuli in schizophrenia: An ERP study. Schizophr Res. 2021 12; 238:128-136. Catalano LT, Wynn JK, Lee J, Green MF. PMID: 34655914.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    32. Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia. Am J Psychiatry. 2021 09 01; 178(9):838-847. Joshi YB, Thomas ML, Braff DL, Green MF, Gur RC, Gur RE, Nuechterlein KH, Stone WS, Greenwood TA, Lazzeroni LC, MacDonald LR, Molina JL, Nungaray JA, Radant AD, Silverman JM, Sprock J, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Swerdlow NR, Light GA. PMID: 33985348; PMCID: PMC8440496.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    33. Clinical and functional effects of the COVID-19 pandemic and social distancing on vulnerable veterans with psychosis or recent homelessness. J Psychiatr Res. 2021 06; 138:42-49. Wynn JK, McCleery A, Novacek D, Reavis EA, Tsai J, Green MF. PMID: 33819876.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCellsPHPublic Health
    34. Predicting response to cognitive training for schizophrenia using results from two studies with different outcomes. Schizophr Res. 2021 05; 231:61-66. Saperstein AM, Choi CJ, Jahshan C, Lynch DA, Wall M, Green MF, Medalia A. PMID: 33770627; PMCID: PMC8222143.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    35. Awareness of illness is associated with better social and nonsocial cognition in recent-onset schizophrenia. Schizophr Res. 2021 05; 231:51-53. Zito MF, Subotnik KL, Ventura J, Kern RS, Green MF, Nuechterlein KH. PMID: 33770625; PMCID: PMC10758255.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. The clinical characterization of the patient with primary psychosis aimed at personalization of management. World Psychiatry. 2021 Feb; 20(1):4-33. Maj M, van Os J, De Hert M, Gaebel W, Galderisi S, Green MF, Guloksuz S, Harvey PD, Jones PB, Malaspina D, McGorry P, Miettunen J, Murray RM, Nuechterlein KH, Peralta V, Thornicroft G, van Winkel R, Ventura J. PMID: 33432763; PMCID: PMC7801854.
      View in: PubMed   Mentions: 83  
    37. Online Social Cognition Training in Schizophrenia: A Double-Blind, Randomized, Controlled Multi-Site Clinical Trial. Schizophr Bull. 2021 01 23; 47(1):108-117. Nahum M, Lee H, Fisher M, Green MF, Hooker CI, Ventura J, Jordan JT, Rose A, Kim SJ, Haut KM, Merzenich MM, Vinogradov S. PMID: 32614046; PMCID: PMC7825077.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    38. Self-stigma in psychotic disorders: Clinical, cognitive, and functional correlates in a diverse sample. Schizophr Res. 2021 02; 228:145-150. Schwarzbold ML, Kern RS, Novacek DM, McGovern JE, Catalano LT, Green MF. PMID: 33444932; PMCID: PMC7987768.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    39. Social Cognitive Networks and Social Cognitive Performance Across Individuals With Schizophrenia Spectrum Disorders and Healthy Control Participants. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 12; 6(12):1202-1214. Oliver LD, Hawco C, Homan P, Lee J, Green MF, Gold JM, DeRosse P, Argyelan M, Malhotra AK, Buchanan RW, Voineskos AN, SPINS Group. PMID: 33579663; PMCID: PMC9289871.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    40. Heritability of acoustic startle magnitude and latency from the consortium on the genetics of schizophrenia. Schizophr Res. 2020 10; 224:33-39. Greenwood TA, Swerdlow NR, Sprock J, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Radant AD, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL, Duncan E. PMID: 33189519; PMCID: PMC7728376.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Requisite Skills and the Meaningful Measurement of Cognition. JAMA Psychiatry. 2020 11 01; 77(11):1103-1104. Keefe RSE, Green MF, Harvey PD. PMID: 32639514.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. Structural and Functional Connectivity of Visual Cortex in Schizophrenia and Bipolar Disorder: A Graph-Theoretic Analysis. Schizophr Bull Open. 2020 Jan; 1(1):sgaa056. Reavis EA, Lee J, Altshuler LL, Cohen MS, Engel SA, Glahn DC, Jimenez AM, Narr KL, Nuechterlein KH, Riedel P, Wynn JK, Green MF. PMID: 33313506; PMCID: PMC7712743.
      View in: PubMed   Mentions: 3  
    43. Do cognition and other person-level characteristics determine housing outcomes among homeless-experienced adults with serious mental illness? Psychiatr Rehabil J. 2021 Jun; 44(2):176-185. Gabrielian S, Hellemann G, Koosis ER, Green MF, Young AS. PMID: 33048564; PMCID: PMC8435461.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    44. Early Visual Processing Is Associated With Social Cognitive Performance in Recent-Onset Schizophrenia. Front Psychiatry. 2020; 11:823. McCleery A, Wynn JK, Lee J, Reavis EA, Ventura J, Subotnik KL, Green MF, Nuechterlein KH. PMID: 33192628; PMCID: PMC7478198.
      View in: PubMed   Mentions: 5  
    45. Effects of aerobic exercise on cardiorespiratory fitness and social functioning in veterans 40 to 65 years old with schizophrenia. Psychiatry Res. 2020 09; 291:113258. Kern RS, Reddy LF, Cohen AN, Young AS, Green MF. PMID: 32763533.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    46. Motivational and cognitive factors linked to community integration in homeless veterans: study 1 - individuals with psychotic disorders. Psychol Med. 2022 Jan; 52(1):169-177. Green MF, Wynn JK, Gabrielian S, Hellemann G, Horan WP, Kern RS, Lee J, Marder SR, Sugar CA. PMID: 32517838.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    47. Experimental approaches to social disconnection in the general community: can we learn from schizophrenia research? World Psychiatry. 2020 Jun; 19(2):177-178. Green MF, Lee J, Wynn JK. PMID: 32394575; PMCID: PMC7215060.
      View in: PubMed   Mentions: 15  
    48. Motivational and cognitive factors linked to community integration in homeless veterans: Study 2 - clinically diverse sample. Psychol Med. 2021 12; 51(16):2915-2922. Wynn JK, Gabrielian S, Hellemann G, Horan WP, Kern RS, Lee J, Marder SR, Sugar CA, Green MF. PMID: 32466807.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    49. Effects of Transcranial Direct Current Stimulation on Visual Neuroplasticity in Schizophrenia. Clin EEG Neurosci. 2020 Nov; 51(6):382-389. Jahshan C, Wynn JK, Roach BJ, Mathalon DH, Green MF. PMID: 32463701.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    50. The effects of age and sex on cognitive impairment in schizophrenia: Findings from the Consortium on the Genetics of Schizophrenia (COGS) study. PLoS One. 2020; 15(5):e0232855. Lee J, Green MF, Nuechterlein KH, Swerdlow NR, Greenwood TA, Hellemann GS, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Gur RC, Gur RE, Braff DL. PMID: 32401791; PMCID: PMC7219730.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    51. Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers. Neuropsychopharmacology. 2020 10; 45(11):1842-1850. Kantrowitz JT, Grinband J, Goff DC, Lahti AC, Marder SR, Kegeles LS, Girgis RR, Sobeih T, Wall MM, Choo TH, Green MF, Yang YS, Lee J, Horga G, Krystal JH, Potter WZ, Javitt DC, Lieberman JA. PMID: 32403118; PMCID: PMC7608251.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    52. Pupillary change on a cognitive effort task in schizophrenia: Associations with cognition and motivation. Int J Psychophysiol. 2020 09; 155:1-7. McGovern JE, Reddy LF, Reavis EA, Green MF. PMID: 32413373.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    53. People with schizophrenia do not show the normal benefits of social versus nonsocial attentional cues. Neuropsychology. 2020 Sep; 34(6):620-628. Catalano LT, Green MF, Wynn JK, Lee J. PMID: 32338943; PMCID: PMC8513804.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    54. From Social Cognition to Negative Symptoms in Schizophrenia: How Do We Get There From Here? Schizophr Bull. 2020 02 26; 46(2):225-226. Green MF. PMID: 31776580; PMCID: PMC7043055.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    55. Profile of cognitive deficits in schizophrenia and factor structure of the Czech MATRICS Consensus Cognitive Battery. Schizophr Res. 2020 04; 218:85-92. Bezdicek O, Michalec J, Kališová L, Kufa T, Dechterenko F, Chlebovcová M, Havlík F, Green MF, Nuechterlein KH. PMID: 32089475.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    56. Associations between physiological responses to social-evaluative stress and daily functioning in first-episode schizophrenia. Schizophr Res. 2020 04; 218:233-239. Reed AC, Lee J, Green MF, Hamilton HK, Miller GA, Subotnik KL, Ventura J, Nuechterlein KH, Yee CM. PMID: 31948901; PMCID: PMC7299766.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    57. Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study. JAMA Psychiatry. 2019 12 01; 76(12):1274-1284. Greenwood TA, Lazzeroni LC, Maihofer AX, Swerdlow NR, Calkins ME, Freedman R, Green MF, Light GA, Nievergelt CM, Nuechterlein KH, Radant AD, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Gur RC, Gur RE, Braff DL. PMID: 31596458; PMCID: PMC6802253.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    58. Reward processing in certain versus uncertain contexts in schizophrenia: An event-related potential (ERP) study. J Abnorm Psychol. 2019 Nov; 128(8):867-880. Clayson PE, Wynn JK, Infantolino ZP, Hajcak G, Green MF, Horan WP. PMID: 31657597; PMCID: PMC6822386.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    59. The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measures. Schizophr Res Cogn. 2020 Mar; 19:100161. Kraus MS, Gold JM, Barch DM, Walker TM, Chun CA, Buchanan RW, Csernansky JG, Goff DC, Green MF, Jarskog LF, Javitt DC, Kimhy D, Lieberman JA, McEvoy JP, Mesholam-Gately RI, Seidman LJ, Ball MP, Kern RS, McMahon RP, Robinson J, Marder SR, Keefe RSE. PMID: 31832342; PMCID: PMC6889798.
      View in: PubMed   Mentions: 2  
    60. Brain glutathione levels and age at onset of illness in chronic schizophrenia. Acta Neuropsychiatr. 2019 Dec; 31(6):343-347. Yang YS, Maddock RJ, Lee J, Zhang H, Hellemann G, Narr KL, Marder SR, Green MF. PMID: 31364526.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    61. Evidence for intact stimulus-specific neural adaptation for visual objects in schizophrenia and bipolar disorder: An ERP study. PLoS One. 2019; 14(8):e0221409. Wynn JK, Engel SA, Lee J, Reavis EA, Green MF. PMID: 31430347; PMCID: PMC6701832.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    62. Evaluating visual neuroplasticity with EEG in schizophrenia outpatients. Schizophr Res. 2019 10; 212:40-46. Wynn JK, Roach BJ, McCleery A, Marder SR, Mathalon DH, Green MF. PMID: 31434625; PMCID: PMC6791734.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    63. Linking resting-state networks and social cognition in schizophrenia and bipolar disorder. Hum Brain Mapp. 2019 11 01; 40(16):4703-4715. Jimenez AM, Riedel P, Lee J, Reavis EA, Green MF. PMID: 31322784; PMCID: PMC6865798.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    64. Effortful goal-directed behavior in schizophrenia: Computational subtypes and associations with cognition. J Abnorm Psychol. 2019 Oct; 128(7):710-722. Cooper JA, Barch DM, Reddy LF, Horan WP, Green MF, Treadway MT. PMID: 31282687; PMCID: PMC6842449.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    65. Nonsocial and social cognition in schizophrenia: current evidence and future directions. World Psychiatry. 2019 Jun; 18(2):146-161. Green MF, Horan WP, Lee J. PMID: 31059632; PMCID: PMC6502429.
      View in: PubMed   Mentions: 168  
    66. fMRI biomarkers of social cognitive skills training in psychosis: Extrinsic and intrinsic functional connectivity. PLoS One. 2019; 14(5):e0214303. Lee J, Jimenez AM, Horan WP, Green MF. PMID: 31100068; PMCID: PMC6524815.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    67. Motivational and cognitive correlates of community integration in homeless veterans entering a permanent supported housing program. Am J Orthopsychiatry. 2020; 90(2):181-192. Horan WP, Wynn JK, Gabrielian S, Glynn SM, Hellemann GS, Kern RS, Lee J, Marder SR, Sugar CA, Green MF. PMID: 31021133; PMCID: PMC6814490.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    68. Reduced Neural Sensitivity to Social vs Nonsocial Reward in Schizophrenia. Schizophr Bull. 2019 04 25; 45(3):620-628. Lee J, Jimenez AM, Reavis EA, Horan WP, Wynn JK, Green MF. PMID: 30189096; PMCID: PMC6483569.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    69. Social exclusion in schizophrenia: Psychological and cognitive consequences. J Psychiatr Res. 2019 07; 114:120-125. Reddy LF, Irwin MR, Breen EC, Reavis EA, Green MF. PMID: 31059992.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    70. The reliability and clinical utility of ICD-11 schizoaffective disorder: A field trial. Schizophr Res. 2019 06; 208:235-241. Peterson DL, Webb CA, Keeley JW, Gaebel W, Zielasek J, Rebello TJ, Robles R, Matsumoto C, Kogan CS, Kulygina M, Farooq S, Green MF, Falkai P, Hasan A, Galderisi S, Larach V, Krasnov V, Reed GM. PMID: 30799218.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    71. N-acetylcysteine improves EEG measures of auditory deviance detection and neural synchronization in schizophrenia: A randomized, controlled pilot study. Schizophr Res. 2019 06; 208:479-480. Yang YS, Davis MC, Wynn JK, Hellemann G, Green MF, Marder SR. PMID: 30712814.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    72. Parsing components of auditory predictive coding in schizophrenia using a roving standard mismatch negativity paradigm. Psychol Med. 2019 05; 49(7):1195-1206. McCleery A, Mathalon DH, Wynn JK, Roach BJ, Hellemann GS, Marder SR, Green MF. PMID: 30642411; PMCID: PMC6499668.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    73. Comparing Tenant and Neighborhood Characteristics of the VA's Project- vs. Tenant-Based Supportive Housing Program in Los Angeles County. J Health Care Poor Underserved. 2019; 30(4):1373-1393. Chinchilla M, Gabrielian S, Horan WP, Glasmeier A, Hellemann G, Wynn JK, Capone-Newton P, Green MF. PMID: 31680103.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    74. fMRI evidence of aberrant neural adaptation for objects in schizophrenia and bipolar disorder. Hum Brain Mapp. 2019 04 01; 40(5):1608-1617. Lee J, Reavis EA, Engel SA, Altshuler LL, Cohen MS, Glahn DC, Nuechterlein KH, Wynn JK, Green MF. PMID: 30575206; PMCID: PMC6655550.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    75. A randomized controlled trial comparing a "bottom-up" and "top-down" approach to cognitive training in schizophrenia. J Psychiatr Res. 2019 02; 109:118-125. Jahshan C, Vinogradov S, Wynn JK, Hellemann G, Green MF. PMID: 30529836; PMCID: PMC9199200.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    76. Resilience in homeless veterans: Clinical and cognitive correlates. Psychiatr Rehabil J. 2019 Sep; 42(3):314-322. Greenberg JM, Wynn JK, Lee J, Hellemann G, Gabrielian S, Green MF. PMID: 30489141.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    77. Social Cognitive Skills Training for Psychosis With Community-Based Training Exercises: A Randomized Controlled Trial. Schizophr Bull. 2018 10 17; 44(6):1254-1266. Horan WP, Dolinsky M, Lee J, Kern RS, Hellemann G, Sugar CA, Glynn SM, Green MF. PMID: 29300973; PMCID: PMC6192506.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    78. Understanding the Association Between Negative Symptoms and Performance on Effort-Based Decision-Making Tasks: The Importance of Defeatist Performance Beliefs. Schizophr Bull. 2018 10 17; 44(6):1217-1226. Reddy LF, Horan WP, Barch DM, Buchanan RW, Gold JM, Marder SR, Wynn JK, Young J, Green MF. PMID: 29140501; PMCID: PMC6192468.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    79. Social vs. non-social measures of learning potential for predicting community functioning across phase of illness in schizophrenia. Schizophr Res. 2019 02; 204:104-110. Clayson PE, Kern RS, Nuechterlein KH, Knowlton BJ, Bearden CE, Cannon TD, Fiske AP, Ghermezi L, Hayata JN, Hellemann GS, Horan WP, Kee K, Lee J, Subotnik KL, Sugar CA, Ventura J, Yee CM, Green MF. PMID: 30121183; PMCID: PMC6377348.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    80. ERP indices of performance monitoring and feedback processing in psychosis: A meta-analysis. Int J Psychophysiol. 2018 10; 132(Pt B):365-378. Martin EA, McCleery A, Moore MM, Wynn JK, Green MF, Horan WP. PMID: 30102934; PMCID: PMC6157731.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    81. Aberrant patterns of neural activity when perceiving emotion from biological motion in schizophrenia. Neuroimage Clin. 2018; 20:380-387. Jimenez AM, Lee J, Reavis EA, Wynn JK, Green MF. PMID: 30128276; PMCID: PMC6095949.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    82. A dose-finding study of oxytocin using neurophysiological measures of social processing. Neuropsychopharmacology. 2019 01; 44(2):289-294. Wynn JK, Green MF, Hellemann G, Reavis EA, Marder SR. PMID: 30082892; PMCID: PMC6300532.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    83. Single transcranial direct current stimulation in schizophrenia: Randomized, cross-over study of neurocognition, social cognition, ERPs, and side effects. PLoS One. 2018; 13(5):e0197023. Rassovsky Y, Dunn W, Wynn JK, Wu AD, Iacoboni M, Hellemann G, Green MF. PMID: 29734347; PMCID: PMC5937783.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    84. Episodic Memory for Dynamic Social Interaction Across Phase of Illness in Schizophrenia. Schizophr Bull. 2018 04 06; 44(3):620-630. Lee J, Nuechterlein KH, Knowlton BJ, Bearden CE, Cannon TD, Fiske AP, Ghermezi L, Hayata JN, Hellemann GS, Horan WP, Kee K, Kern RS, Subotnik KL, Sugar CA, Ventura J, Yee CM, Green MF. PMID: 29106694; PMCID: PMC5890490.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    85. Pupillary responses to a cognitive effort task in schizophrenia. Schizophr Res. 2018 09; 199:53-57. Reddy LF, Reavis EA, Wynn JK, Green MF. PMID: 29526458.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    86. Clinical and cognitive correlates of unsheltered status in homeless persons with psychotic disorders. Schizophr Res. 2018 07; 197:421-427. Llerena K, Gabrielian S, Green MF. PMID: 29486957.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    87. Social Disconnection in Schizophrenia and the General Community. Schizophr Bull. 2018 02 15; 44(2):242-249. Green MF, Horan WP, Lee J, McCleery A, Reddy LF, Wynn JK. PMID: 28637195; PMCID: PMC5814840.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    88. Hallucinations, neuroplasticity, and prediction errors in schizophrenia. Scand J Psychol. 2018 02; 59(1):41-48. McCleery A, Wynn JK, Mathalon DH, Green MF. PMID: 29356009; PMCID: PMC5969574.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    89. Improving Work Outcome in Supported Employment for Serious Mental Illness: Results From 2 Independent Studies of Errorless Learning. Schizophr Bull. 2018 01 13; 44(1):38-45. Kern RS, Zarate R, Glynn SM, Turner LR, Smith KM, Mitchell SS, Sugar CA, Bell MD, Liberman RP, Kopelowicz A, Green MF. PMID: 28981901; PMCID: PMC5768051.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    90. The neural correlates of self-referential memory encoding and retrieval in schizophrenia. Neuropsychologia. 2018 01 31; 109:19-27. Jimenez AM, Lee J, Wynn JK, Green MF. PMID: 29217224.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    91. The effects of curcumin on brain-derived neurotrophic factor and cognition in schizophrenia: A randomized controlled study. Schizophr Res. 2018 05; 195:572-573. Wynn JK, Green MF, Hellemann G, Karunaratne K, Davis MC, Marder SR. PMID: 28965778.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    92. Enhancing Neuroplasticity to Augment Cognitive Remediation in Schizophrenia. Front Psychiatry. 2017; 8:191. Jahshan C, Rassovsky Y, Green MF. PMID: 29021765; PMCID: PMC5623668.
      View in: PubMed   Mentions: 9  
    93. Assessing neural tuning for object perception in schizophrenia and bipolar disorder with multivariate pattern analysis of fMRI data. Neuroimage Clin. 2017; 16:491-497. Reavis EA, Lee J, Wynn JK, Engel SA, Cohen MS, Nuechterlein KH, Glahn DC, Altshuler LL, Green MF. PMID: 28932681; PMCID: PMC5596305.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    94. Treatment of social cognition in schizophrenia: Current status and future directions. Schizophr Res. 2019 01; 203:3-11. Horan WP, Green MF. PMID: 28712968.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    95. The effect of bilateral transcranial direct current stimulation on early auditory processing in schizophrenia: a preliminary study. J Neural Transm (Vienna). 2017 09; 124(9):1145-1149. Dunn W, Rassovsky Y, Wynn J, Wu AD, Iacoboni M, Hellemann G, Green MF. PMID: 28687908.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    96. Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension. Schizophr Res. 2018 08; 198:6-15. Swerdlow NR, Light GA, Thomas ML, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 28549722; PMCID: PMC5700873.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    97. Cortical Thickness of Functionally Defined Visual Areas in Schizophrenia and Bipolar Disorder. Cereb Cortex. 2017 05 01; 27(5):2984-2993. Reavis EA, Lee J, Wynn JK, Engel SA, Jimenez AM, Green MF. PMID: 27226446; PMCID: PMC6059190.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    98. Enhancing tolerability of a measure of social perception in schizophrenia: comparison of short and long Norwegian versions of the Relationships Across Domains test. Cogn Neuropsychiatry. 2017 May; 22(3):254-262. Vaskinn A, Fiske AP, Green MF. PMID: 28346041.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    99. Cognitive correlates of visual neural plasticity in schizophrenia. Schizophr Res. 2017 12; 190:39-45. Jahshan C, Wynn JK, Mathalon DH, Green MF. PMID: 28336195.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    100. Linking optic radiation volume to visual perception in schizophrenia and bipolar disorder. Schizophr Res. 2017 12; 190:102-106. Reavis EA, Lee J, Wynn JK, Narr KL, Njau SN, Engel SA, Green MF. PMID: 28318839; PMCID: PMC5600632.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    101. Altered experiential, but not hypothetical, delay discounting in schizophrenia. J Abnorm Psychol. 2017 Apr; 126(3):301-311. Horan WP, Johnson MW, Green MF. PMID: 28165261; PMCID: PMC5378609.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    102. Functional connectivity when detecting rare visual targets in schizophrenia. Psychiatry Res Neuroimaging. 2017 Mar 30; 261:35-43. Jimenez AM, Lee J, Green MF, Wynn JK. PMID: 28126618; PMCID: PMC5333783.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    103. Improving measurement of attributional style in schizophrenia; A psychometric evaluation of the Ambiguous Intentions Hostility Questionnaire (AIHQ). J Psychiatr Res. 2017 06; 89:48-54. Buck B, Iwanski C, Healey KM, Green MF, Horan WP, Kern RS, Lee J, Marder SR, Reise SP, Penn DL. PMID: 28160626.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    104. Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia. JAMA Psychiatry. 2017 Jan 01; 74(1):37-46. Thomas ML, Green MF, Hellemann G, Sugar CA, Tarasenko M, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Shiluk AL, Siever LJ, Silverman JM, Sprock J, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL, Light GA. PMID: 27926742; PMCID: PMC5453308.
      View in: PubMed   Mentions: 89     Fields:    Translation:Humans
    105. Deconstructing Bipolar Disorder and Schizophrenia: A cross-diagnostic cluster analysis of cognitive phenotypes. J Affect Disord. 2017 Feb; 209:71-79. Lee J, Rizzo S, Altshuler L, Glahn DC, Miklowitz DJ, Sugar CA, Wynn JK, Green MF. PMID: 27888723; PMCID: PMC6655479.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    106. Neural Correlates of Belief and Emotion Attribution in Schizophrenia. PLoS One. 2016; 11(11):e0165546. Lee J, Horan WP, Wynn JK, Green MF. PMID: 27812142; PMCID: PMC5094726.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    107. Assessment of attachment in psychosis: A psychometric cause for concern. Psychiatry Res. 2016 Dec 30; 246:77-83. Olbert CM, Penn DL, Reise SP, Horan WP, Kern RS, Lee J, Green MF. PMID: 27664549.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    108. Social Preference and Glutamatergic Dysfunction: Underappreciated Prerequisites for Social Dysfunction in Schizophrenia. Trends Neurosci. 2016 09; 39(9):587-596. Lee J, Green MF. PMID: 27477199; PMCID: PMC5951176.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimals
    109. Longitudinal stability of social cognition in schizophrenia: A 5-year follow-up of social perception and emotion processing. Schizophr Res. 2016 10; 176(2-3):467-472. McCleery A, Lee J, Fiske AP, Ghermezi L, Hayata JN, Hellemann GS, Horan WP, Kee KS, Kern RS, Knowlton BJ, Subotnik KL, Ventura J, Sugar CA, Nuechterlein KH, Green MF. PMID: 27443808; PMCID: PMC5026923.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    110. Approaching anger in schizophrenia: What an implicit task tells you that self-report does not. Schizophr Res. 2016 10; 176(2-3):514-519. Reddy LF, Green MF, Wynn JK, Rinck M, Horan WP. PMID: 27242068.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    111. Patterns and reliability of EEG during error monitoring for internal versus external feedback in schizophrenia. Int J Psychophysiol. 2016 07; 105:39-46. Llerena K, Wynn JK, Hajcak G, Green MF, Horan WP. PMID: 27166742.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    112. Modulation of neurophysiological auditory processing measures by bilateral transcranial direct current stimulation in schizophrenia. Schizophr Res. 2016 07; 174(1-3):189-191. Dunn W, Rassovsky Y, Wynn JK, Wu AD, Iacoboni M, Hellemann G, Green MF. PMID: 27132485.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    113. Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study. Schizophr Res. 2016 07; 174(1-3):1-9. Millard SP, Shofer J, Braff D, Calkins M, Cadenhead K, Freedman R, Green MF, Greenwood TA, Gur R, Gur R, Lazzeroni LC, Light GA, Olincy A, Nuechterlein K, Seidman L, Siever L, Silverman J, Stone WS, Sprock J, Sugar CA, Swerdlow NR, Tsuang M, Turetsky B, Radant A, Tsuang DW. PMID: 27132484; PMCID: PMC4912929.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    114. Abnormal Ventral and Dorsal Attention Network Activity during Single and Dual Target Detection in Schizophrenia. Front Psychol. 2016; 7:323. Jimenez AM, Lee J, Wynn JK, Cohen MS, Engel SA, Glahn DC, Nuechterlein KH, Reavis EA, Green MF. PMID: 27014135; PMCID: PMC4781842.
      View in: PubMed   Mentions: 19  
    115. Probabilistic Reversal Learning in Schizophrenia: Stability of Deficits and Potential Causal Mechanisms. Schizophr Bull. 2016 07; 42(4):942-51. Reddy LF, Waltz JA, Green MF, Wynn JK, Horan WP. PMID: 26884546; PMCID: PMC4903059.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    116. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers. Schizophr Res. 2016 Apr; 172(1-3):106-13. Stone WS, Mesholam-Gately RI, Giuliano AJ, Woodberry KA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, McCarley RW, Heinssen R, Green MF, Nuechterlein K, Seidman LJ. PMID: 26896388; PMCID: PMC5410891.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    117. Distinct patterns of dysfunctional appetitive and aversive motivation in bipolar disorder versus schizophrenia: An event-related potential study. J Abnorm Psychol. 2016 05; 125(4):576-87. Horan WP, Wynn JK, Hajcak G, Altshuler L, Green MF. PMID: 26845261; PMCID: PMC4850103.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    118. Impact of cognitive and social cognitive impairment on functional outcomes in patients with schizophrenia. J Clin Psychiatry. 2016 Feb; 77 Suppl 2:8-11. Green MF. PMID: 26919052.
      View in: PubMed   Mentions: 92     Fields:    Translation:Humans
    119. Pain empathy in schizophrenia: an fMRI study. Soc Cogn Affect Neurosci. 2016 05; 11(5):783-92. Horan WP, Jimenez AM, Lee J, Wynn JK, Eisenberger NI, Green MF. PMID: 26746181; PMCID: PMC4847698.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    120. Motivational Deficits and Negative Symptoms in Schizophrenia: Concepts and Assessments. Curr Top Behav Neurosci. 2016; 27:357-73. Reddy LF, Horan WP, Green MF. PMID: 26164592.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    121. Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study. Schizophr Res. 2016 Jan; 170(1):30-40. Greenwood TA, Lazzeroni LC, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 26597662; PMCID: PMC4707095.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    122. Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History. Am J Psychiatry. 2016 Apr 01; 173(4):385-91. Greenwood TA, Light GA, Swerdlow NR, Calkins ME, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Freedman R, Braff DL. PMID: 26441157; PMCID: PMC4933520.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    123. Social cognition in schizophrenia. Nat Rev Neurosci. 2015 Oct; 16(10):620-31. Green MF, Horan WP, Lee J. PMID: 26373471.
      View in: PubMed   Mentions: 310     Fields:    Translation:Humans
    124. The Polish Academic Version of the MATRICS Consensus Cognitive Battery (MCCB): Evaluation of Psychometric Properties. Psychiatr Q. 2015 Sep; 86(3):435-47. Jedrasik-Styla M, Ciolkiewicz A, Styla R, Linke M, Parnowska D, Gruszka A, Denisiuk M, Jarema M, Green MF, Wichniak A. PMID: 25601030; PMCID: PMC4546693.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    125. Impaired target detection in schizophrenia and the ventral attentional network: Findings from a joint event-related potential-functional MRI analysis. Neuroimage Clin. 2015; 9:95-102. Wynn JK, Jimenez AM, Roach BJ, Korb A, Lee J, Horan WP, Ford JM, Green MF. PMID: 26448909; PMCID: PMC4552813.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    126. Mindfulness in schizophrenia: Associations with self-reported motivation, emotion regulation, dysfunctional attitudes, and negative symptoms. Schizophr Res. 2015 Oct; 168(1-2):537-42. Tabak NT, Horan WP, Green MF. PMID: 26232242; PMCID: PMC4591204.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    127. Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 2—External Validity and Correlates. Schizophr Bull. 2015 Sep; 41(5):1055-65. Horan WP, Reddy LF, Barch DM, Buchanan RW, Dunayevich E, Gold JM, Marder SR, Wynn JK, Young JW, Green MF. PMID: 26209546; PMCID: PMC4535650.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    128. Randomized controlled trial of computer-based treatment of social cognition in schizophrenia: the TRuSST trial protocol. BMC Psychiatry. 2015 Jul 03; 15:142. Rose A, Vinogradov S, Fisher M, Green MF, Ventura J, Hooker C, Merzenich M, Nahum M. PMID: 26138715; PMCID: PMC4489025.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    129. Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1—Psychometric Characteristics of 5 Paradigms. Schizophr Bull. 2015 Sep; 41(5):1045-54. Reddy LF, Horan WP, Barch DM, Buchanan RW, Dunayevich E, Gold JM, Lyons N, Marder SR, Treadway MT, Wynn JK, Young JW, Green MF. PMID: 26142081; PMCID: PMC4535649.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    130. Effort-Based Decision Making in Schizophrenia: Evaluation of Paradigms to Measure Motivational Deficits. Schizophr Bull. 2015 Sep; 41(5):1021-3. Green MF, Horan WP. PMID: 26108868; PMCID: PMC4535648.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    131. Effort-Based Decision Making: A Novel Approach for Assessing Motivation in Schizophrenia. Schizophr Bull. 2015 Sep; 41(5):1035-44. Green MF, Horan WP, Barch DM, Gold JM. PMID: 26089350; PMCID: PMC4535644.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    132. Social Cognition Psychometric Evaluation: Results of the Initial Psychometric Study. Schizophr Bull. 2016 Mar; 42(2):494-504. Pinkham AE, Penn DL, Green MF, Harvey PD. PMID: 25943125; PMCID: PMC4753585.
      View in: PubMed   Mentions: 96     Fields:    Translation:Humans
    133. Structure and correlates of self-reported empathy in schizophrenia. J Psychiatr Res. 2015 Jul-Aug; 66-67:60-6. Horan WP, Reise SP, Kern RS, Lee J, Penn DL, Green MF. PMID: 25985922; PMCID: PMC4458171.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    134. The effect of transcranial direct current stimulation on social cognition in schizophrenia: A preliminary study. Schizophr Res. 2015 Jul; 165(2-3):171-4. Rassovsky Y, Dunn W, Wynn J, Wu AD, Iacoboni M, Hellemann G, Green MF. PMID: 25934168.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    135. Neurocognitive performance in family-based and case-control studies of schizophrenia. Schizophr Res. 2015 Apr; 163(1-3):17-23. Gur RC, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Gur RE. PMID: 25432636; PMCID: PMC4441547.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    136. EEG findings of reduced neural synchronization during visual integration in schizophrenia. PLoS One. 2015; 10(3):e0119849. Wynn JK, Roach BJ, Lee J, Horan WP, Ford JM, Jimenez AM, Green MF. PMID: 25785939; PMCID: PMC4364708.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    137. The "Right Stuff" Revisited: What Have We Learned About the Determinants of Daily Functioning in Schizophrenia? Schizophr Bull. 2015 Jul; 41(4):781-5. Green MF, Llerena K, Kern RS. PMID: 25750248; PMCID: PMC4466185.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    138. Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res. 2015 Apr; 163(1-3):38-46. Nuechterlein KH, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 25749017; PMCID: PMC4382444.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    139. A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy. Schizophr Res. 2015 May; 164(1-3):136-42. Jarskog LF, Lowy MT, Grove RA, Keefe RS, Horrigan JP, Ball MP, Breier A, Buchanan RW, Carter CS, Csernansky JG, Goff DC, Green MF, Kantrowitz JT, Keshavan MS, Laurelle M, Lieberman JA, Marder SR, Maruff P, McMahon RP, Seidman LJ, Peykamian MA. PMID: 25728831.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    140. Factor structure and heritability of endophenotypes in schizophrenia: findings from the Consortium on the Genetics of Schizophrenia (COGS-1). Schizophr Res. 2015 Apr; 163(1-3):73-9. Seidman LJ, Hellemann G, Nuechterlein KH, Greenwood TA, Braff DL, Cadenhead KS, Calkins ME, Freedman R, Gur RE, Gur RC, Lazzeroni LC, Light GA, Olincy A, Radant AD, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar C, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Green MF. PMID: 25682549; PMCID: PMC5944296.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    141. Perceived emotional intelligence is impaired and associated with poor community functioning in schizophrenia and bipolar disorder. Schizophr Res. 2015 Mar; 162(1-3):189-95. Tabak NT, Green MF, Wynn JK, Proudfit GH, Altshuler L, Horan WP. PMID: 25579055; PMCID: PMC4339495.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    142. Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies. Schizophr Res. 2015 Apr; 163(1-3):47-52. Radant AD, Millard SP, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Meichle SP, Nuechterlein KH, Olincy A, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Sugar CA, Tsuang MT, Turetsky BI, Tsuang DW. PMID: 25553977; PMCID: PMC4382408.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    143. The neurophysiology of biological motion perception in schizophrenia. Brain Behav. 2015 Jan; 5(1):75-84. Jahshan C, Wynn JK, Mathis KI, Green MF. PMID: 25722951; PMCID: PMC4321396.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    144. California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res. 2015 Apr; 163(1-3):32-7. Stone WS, Mesholam-Gately RI, Braff DL, Calkins ME, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Siever LJ, Silverman JM, Sprock J, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Seidman LJ. PMID: 25497440; PMCID: PMC5954831.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    145. The MATRICS consensus cognitive battery: what we know 6 years later. Am J Psychiatry. 2014 Nov 01; 171(11):1151-4. Green MF, Harris JG, Nuechterlein KH. PMID: 25756630.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    146. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2. Schizophr Res. 2015 Apr; 163(1-3):63-72. Light GA, Swerdlow NR, Thomas ML, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Pela M, Radant AD, Seidman LJ, Sharp RF, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Braff DL, Turetsky BI. PMID: 25449710; PMCID: PMC4382452.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    147. Approach and withdrawal motivation in schizophrenia: an examination of frontal brain asymmetric activity. PLoS One. 2014; 9(10):e110007. Horan WP, Wynn JK, Mathis I, Miller GA, Green MF. PMID: 25310340; PMCID: PMC4195662.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    148. Social cognition and functional outcome in schizophrenia: The moderating role of cardiac vagal tone. J Abnorm Psychol. 2014 Nov; 123(4):764-770. Hamilton HK, Sun JC, Green MF, Kee KS, Lee J, Sergi M, Sholty GL, Mathis KI, Jetton C, Williams TJ, Kern R, Horan W, Fiske A, Subotnik KL, Ventura J, Hellemann G, Nuechterlein KH, Yee CM. PMID: 25314266; PMCID: PMC4227946.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    149. The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2. Schizophr Res. 2015 Apr; 163(1-3):53-62. Turetsky BI, Dress EM, Braff DL, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Light G. PMID: 25306203; PMCID: PMC4382423.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    150. Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) study: the moderating role of smoking status and antipsychotic medications. Schizophr Res. 2015 Apr; 163(1-3):24-31. Lee J, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 25248939; PMCID: PMC4368500.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    151. Associations between oxytocin receptor genotypes and social cognitive performance in individuals with schizophrenia. Schizophr Res. 2014 Nov; 159(2-3):353-7. Davis MC, Horan WP, Nurmi EL, Rizzo S, Li W, Sugar CA, Green MF. PMID: 25244972; PMCID: PMC4254299.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    152. Some markers of mirroring appear intact in schizophrenia: evidence from mu suppression. Cogn Affect Behav Neurosci. 2014 Sep; 14(3):1049-60. Horan WP, Pineda JA, Wynn JK, Iacoboni M, Green MF. PMID: 24415272.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    153. Detecting reliable cognitive change in individual patients with the MATRICS Consensus Cognitive Battery. Schizophr Res. 2014 Oct; 159(1):182-7. Gray BE, McMahon RP, Green MF, Seidman LJ, Mesholam-Gately RI, Kern RS, Nuechterlein KH, Keefe RS, Gold JM. PMID: 25156338; PMCID: PMC4469996.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    154. Behavioral approach and avoidance in schizophrenia: an evaluation of motivational profiles. Schizophr Res. 2014 Oct; 159(1):164-70. Felice Reddy L, Green MF, Rizzo S, Sugar CA, Blanchard JJ, Gur RE, Kring AM, Horan WP. PMID: 25153364; PMCID: PMC4177267.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    155. Exploring facial emotion perception in schizophrenia using transcranial magnetic stimulation and spatial filtering. J Psychiatr Res. 2014 Nov; 58:102-8. Rassovsky Y, Lee J, Nori P, Wu AD, Iacoboni M, Breitmeyer BG, Hellemann G, Green MF. PMID: 25106071.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    156. Self-reported empathy and neural activity during action imitation and observation in schizophrenia. Neuroimage Clin. 2014; 5:100-8. Horan WP, Iacoboni M, Cross KA, Korb A, Lee J, Nori P, Quintana J, Wynn JK, Green MF. PMID: 25009771; PMCID: PMC4087183.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    157. Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study. Schizophr Bull. 2014 Nov; 40(6):1404-11. Light G, Greenwood TA, Swerdlow NR, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 24903414; PMCID: PMC4193725.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    158. Paternal age of schizophrenia probands and endophenotypic differences from unaffected siblings. Psychiatry Res. 2014 Sep 30; 219(1):67-71. Schmeidler J, Lazzeroni LC, Swerdlow NR, Ferreira RP, Braff DL, Calkins ME, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Olincy A, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Stone WS, Sprock J, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Silverman JM. PMID: 24913833; PMCID: PMC4110721.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    159. Meta-analysis of face processing event-related potentials in schizophrenia. Biol Psychiatry. 2015 Jan 15; 77(2):116-26. McCleery A, Lee J, Joshi A, Wynn JK, Hellemann GS, Green MF. PMID: 24923618.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    160. Neural substrates of visual masking by object substitution in schizophrenia. Hum Brain Mapp. 2014 Sep; 35(9):4654-62. Lee J, Cohen MS, Engel SA, Glahn D, Nuechterlein KH, Wynn JK, Green MF. PMID: 24677632; PMCID: PMC6716599.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    161. Oxytocin-augmented social cognitive skills training in schizophrenia. Neuropsychopharmacology. 2014 Aug; 39(9):2070-7. Davis MC, Green MF, Lee J, Horan WP, Senturk D, Clarke AD, Marder SR. PMID: 24637803; PMCID: PMC4104336.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    162. A novel, online social cognitive training program for young adults with schizophrenia: A pilot study. Schizophr Res Cogn. 2014 Mar 01; 1(1):e11-e19. Nahum M, Fisher M, Loewy R, Poelke G, Ventura J, Nuechterlein KH, Hooker CI, Green MF, Merzenich M, Vinogradov S. PMID: 25267937; PMCID: PMC4175473.
      View in: PubMed   Mentions: 45  
    163. Cognition in schizophrenia: Past, present, and future. Schizophr Res Cogn. 2014 Mar; 1(1):e1-e9. Green MF, Harvey PD. PMID: 25254156; PMCID: PMC4171037.
      View in: PubMed   Mentions: 77  
    164. Is there an association between advanced paternal age and endophenotype deficit levels in schizophrenia? PLoS One. 2014; 9(2):e88379. Tsuang D, Esterberg M, Braff D, Calkins M, Cadenhead K, Dobie D, Freedman R, Green MF, Greenwood T, Gur R, Gur R, Horan W, Lazzeroni LC, Light GA, Millard SP, Olincy A, Nuechterlein K, Seidman L, Siever L, Silverman J, Stone W, Sprock J, Sugar C, Swerdlow N, Tsuang M, Turetsky B, Radant A. PMID: 24523888; PMCID: PMC3921166.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    165. Multisensory integration in schizophrenia: a behavioural and event-related potential study. Cogn Neuropsychiatry. 2014; 19(4):319-36. Wynn JK, Jahshan C, Green MF. PMID: 24397788; PMCID: PMC4103881.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    166. Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS. Schizophr Res. 2014 Feb; 152(2-3):503-12. Swerdlow NR, Light GA, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Ray A, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 24405980; PMCID: PMC3960985.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    167. Cross-diagnostic comparison of visual processing in bipolar disorder and schizophrenia. J Psychiatr Res. 2014 Apr; 51:42-8. Jahshan C, Wynn JK, McCleery A, Glahn DC, Altshuler LL, Green MF. PMID: 24433849; PMCID: PMC4519235.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    168. Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor. JAMA Psychiatry. 2013 Dec; 70(12):1267-75. Lane HY, Lin CH, Green MF, Hellemann G, Huang CC, Chen PW, Tun R, Chang YC, Tsai GE. PMID: 24089054.
      View in: PubMed   Mentions: 97     Fields:    Translation:Humans
    169. Structural abnormalities in cortical volume, thickness, and surface area in 22q11.2 microdeletion syndrome: Relationship with psychotic symptoms. Neuroimage Clin. 2013; 3:405-15. Jalbrzikowski M, Jonas R, Senturk D, Patel A, Chow C, Green MF, Bearden CE. PMID: 24273724; PMCID: PMC3814944.
      View in: PubMed   Mentions: 49     Fields:    
    170. Adapting social neuroscience measures for schizophrenia clinical trials, part 3: fathoming external validity. Schizophr Bull. 2013 Nov; 39(6):1211-8. Olbert CM, Penn DL, Kern RS, Lee J, Horan WP, Reise SP, Ochsner KN, Marder SR, Green MF. PMID: 24072806; PMCID: PMC3796091.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    171. Adapting social neuroscience measures for schizophrenia clinical trials, Part 2: trolling the depths of psychometric properties. Schizophr Bull. 2013 Nov; 39(6):1201-10. Kern RS, Penn DL, Lee J, Horan WP, Reise SP, Ochsner KN, Marder SR, Green MF. PMID: 24072805; PMCID: PMC3796089.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    172. Going from social neuroscience to schizophrenia clinical trials. Schizophr Bull. 2013 Nov; 39(6):1189-91. Green MF, Penn DL. PMID: 24072810; PMCID: PMC3796090.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    173. Adapting social neuroscience measures for schizophrenia clinical trials, Part 1: ferrying paradigms across perilous waters. Schizophr Bull. 2013 Nov; 39(6):1192-200. Green MF, Lee J, Ochsner KN. PMID: 24072811; PMCID: PMC3796092.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    174. Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia. Schizophr Res. 2013 Nov; 150(2-3):328-33. Marder SR, Alphs L, Anghelescu IG, Arango C, Barnes TR, Caers I, Daniel DG, Dunayevich E, Fleischhacker WW, Garibaldi G, Green MF, Harvey PD, Kahn RS, Kane JM, Keefe RS, Kinon B, Leucht S, Lindenmayer JP, Malhotra AK, Stauffer V, Umbricht D, Wesnes K, Kapur S, Rabinowitz J. PMID: 24028744.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    175. Impulsivity and risk taking in bipolar disorder and schizophrenia. Neuropsychopharmacology. 2014 Jan; 39(2):456-63. Reddy LF, Lee J, Davis MC, Altshuler L, Glahn DC, Miklowitz DJ, Green MF. PMID: 23963117; PMCID: PMC3870783.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    176. Adapting and evaluating a social cognitive remediation program for schizophrenia in Arabic. Schizophr Res. 2013 Aug; 148(1-3):12-7. Gohar SM, Hamdi E, El Ray LA, Horan WP, Green MF. PMID: 23756297.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    177. The social cognition psychometric evaluation study: results of the expert survey and RAND panel. Schizophr Bull. 2014 Jul; 40(4):813-23. Pinkham AE, Penn DL, Green MF, Buck B, Healey K, Harvey PD. PMID: 23728248; PMCID: PMC4059426.
      View in: PubMed   Mentions: 147     Fields:    Translation:Humans
    178. Effects of single dose intranasal oxytocin on social cognition in schizophrenia. Schizophr Res. 2013 Jul; 147(2-3):393-7. Davis MC, Lee J, Horan WP, Clarke AD, McGee MR, Green MF, Marder SR. PMID: 23676253.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCTClinical Trials
    179. Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry. 2013 May; 170(5):521-32. Greenwood TA, Swerdlow NR, Gur RE, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Ray A, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Light GA, Braff DL. PMID: 23511790; PMCID: PMC3878873.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    180. Assessing temporal processing of facial emotion perception with transcranial magnetic stimulation. Brain Behav. 2013 May; 3(3):263-72. Rassovsky Y, Lee J, Nori P, D Wu A, Iacoboni M, Breitmeyer BG, Hellemann G, Green MF. PMID: 23785658; PMCID: PMC3683286.
      View in: PubMed   Mentions:    Fields:    
    181. Social and nonsocial cognition in bipolar disorder and schizophrenia: relative levels of impairment. Am J Psychiatry. 2013 Mar; 170(3):334-41. Lee J, Altshuler L, Glahn DC, Miklowitz DJ, Ochsner K, Green MF. PMID: 23450289; PMCID: PMC3869864.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    182. Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. J Psychiatr Res. 2013 Jun; 47(6):783-90. Strauss GP, Horan WP, Kirkpatrick B, Fischer BA, Keller WR, Miski P, Buchanan RW, Green MF, Carpenter WT. PMID: 23453820; PMCID: PMC3686506.
      View in: PubMed   Mentions: 138     Fields:    Translation:Humans
    183. Sex differences in familiality effects on neurocognitive performance in schizophrenia. Biol Psychiatry. 2013 May 15; 73(10):976-84. Calkins ME, Ray A, Gur RC, Freedman R, Green MF, Greenwood TA, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar C, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL, Lazzeroni LC, Gur RE. PMID: 23395246; PMCID: PMC3954126.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    184. Object substitution masking in schizophrenia: an event-related potential analysis. Front Psychol. 2013; 4:30. Wynn JK, Mathis KI, Ford J, Breitmeyer BG, Green MF. PMID: 23382723; PMCID: PMC3563043.
      View in: PubMed   Mentions: 5  
    185. Response to Vakalopoulos' letter to the editor Re: Nonconscious and conscious color priming in schizophrenia. J Psychiatr Res. 2013 Jan; 47(1):138-9. Breitmeyer BG, Jahshan C, Wynn JK, Green MF. PMID: 23157801.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    186. Relationship between auditory processing and affective prosody in schizophrenia. Schizophr Res. 2013 Feb; 143(2-3):348-53. Jahshan C, Wynn JK, Green MF. PMID: 23276478; PMCID: PMC3551533.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    187. Has the generalized deficit become the generalized criticism? Schizophr Bull. 2013 Mar; 39(2):257-62. Green MF, Horan WP, Sugar CA. PMID: 23236079; PMCID: PMC3576178.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    188. From perception to functional outcome in schizophrenia: modeling the role of ability and motivation. Arch Gen Psychiatry. 2012 Dec; 69(12):1216-24. Green MF, Hellemann G, Horan WP, Lee J, Wynn JK. PMID: 23026889; PMCID: PMC3976993.
      View in: PubMed   Mentions: 174     Fields:    
    189. Social cognition in 22q11.2 microdeletion syndrome: relevance to psychosis? Schizophr Res. 2012 Dec; 142(1-3):99-107. Jalbrzikowski M, Carter C, Senturk D, Chow C, Hopkins JM, Green MF, Galván A, Cannon TD, Bearden CE. PMID: 23122739; PMCID: PMC3714207.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    190. Nonconscious and conscious color priming in schizophrenia. J Psychiatr Res. 2012 Oct; 46(10):1312-7. Jahshan C, Wynn JK, Breitmeyer BG, Green MF. PMID: 22785333; PMCID: PMC3432669.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    191. An electrophysiological investigation of attentional blink in schizophrenia: separating perceptual and attentional processes. Int J Psychophysiol. 2012 Oct; 86(1):108-13. Mathis KI, Wynn JK, Jahshan C, Hellemann G, Darque A, Green MF. PMID: 22771850.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    192. Factor structure of emotional intelligence in schizophrenia. Schizophr Res. 2012 Aug; 139(1-3):78-81. Lin YC, Wynn JK, Hellemann G, Green MF. PMID: 22584064; PMCID: PMC3393835.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    193. The puzzle of schizophrenia: tracking the core role of cognitive deficits. Dev Psychopathol. 2012 May; 24(2):529-36. Nuechterlein KH, Subotnik KL, Ventura J, Green MF, Gretchen-Doorly D, Asarnow RF. PMID: 22559128.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    194. Cross-diagnostic comparison of duration mismatch negativity and P3a in bipolar disorder and schizophrenia. Bipolar Disord. 2012 May; 14(3):239-48. Jahshan C, Wynn JK, Mathis KI, Altshuler LL, Glahn DC, Green MF. PMID: 22548897; PMCID: PMC3342839.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    195. An intact social cognitive process in schizophrenia: situational context effects on perception of facial affect. Schizophr Bull. 2013 May; 39(3):640-7. Lee J, Kern RS, Harvey PO, Horan WP, Kee KS, Ochsner K, Penn DL, Green MF. PMID: 22532704; PMCID: PMC3627776.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    196. Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation. Schizophr Res. 2012 Sep; 140(1-3):1-8. Harvey PD, Heaton RK, Carpenter WT, Green MF, Gold JM, Schoenbaum M. PMID: 22503642; PMCID: PMC3399960.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    197. Diagnosis of schizophrenia: consistency across information sources and stability of the condition. Schizophr Res. 2012 Sep; 140(1-3):9-14. Harvey PD, Heaton RK, Carpenter WT, Green MF, Gold JM, Schoenbaum M. PMID: 22503641; PMCID: PMC3399919.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    198. Neural substrates of empathic accuracy in people with schizophrenia. Schizophr Bull. 2013 May; 39(3):617-28. Harvey PO, Zaki J, Lee J, Ochsner K, Green MF. PMID: 22451493; PMCID: PMC3627780.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    199. Neural bases of emotional experience versus perception in schizophrenia. Biol Psychiatry. 2012 Jan 15; 71(2):96-7. Green MF, Lee J. PMID: 22152783.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    200. Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophr Res. 2012 Apr; 136(1-3):25-31. Javitt DC, Buchanan RW, Keefe RS, Kern R, McMahon RP, Green MF, Lieberman J, Goff DC, Csernansky JG, McEvoy JP, Jarskog F, Seidman LJ, Gold JM, Kimhy D, Nolan KS, Barch DS, Ball MP, Robinson J, Marder SR. PMID: 22169248.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    201. Intact motivated attention in schizophrenia: evidence from event-related potentials. Schizophr Res. 2012 Mar; 135(1-3):95-9. Horan WP, Foti D, Hajcak G, Wynn JK, Green MF. PMID: 22126898; PMCID: PMC3288557.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    202. Perceptual measurement in schizophrenia: promising electrophysiology and neuroimaging paradigms from CNTRICS. Schizophr Bull. 2012 Jan; 38(1):81-91. Butler PD, Chen Y, Ford JM, Geyer MA, Silverstein SM, Green MF. PMID: 21890745; PMCID: PMC3245585.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    203. Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophr Bull. 2011 Sep; 37 Suppl 2:S33-40. Nuechterlein KH, Subotnik KL, Green MF, Ventura J, Asarnow RF, Gitlin MJ, Yee CM, Gretchen-Doorly D, Mintz J. PMID: 21860045; PMCID: PMC3160123.
      View in: PubMed   Mentions: 115     Fields:    Translation:Humans
    204. The impact of neurocognitive impairment on occupational recovery of clinically stable patients with bipolar disorder: a prospective study. Bipolar Disord. 2011 Jun; 13(4):323-33. Bearden CE, Shih VH, Green MF, Gitlin M, Sokolski KN, Levander E, Marusak S, Hammen C, Sugar CA, Altshuler LL. PMID: 21843272; PMCID: PMC3157039.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    205. Visual masking in schizophrenia: overview and theoretical implications. Schizophr Bull. 2011 Jul; 37(4):700-8. Green MF, Lee J, Wynn JK, Mathis KI. PMID: 21606322; PMCID: PMC3122285.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    206. Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders. Biol Psychiatry. 2011 Jul 01; 70(1):7-12. Carter CS, Barch DM, Bullmore E, Breiling J, Buchanan RW, Butler P, Cohen JD, Geyer M, Gollub R, Green MF, Jaeger J, Krystal JH, Moore H, Nuechterlein K, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T. PMID: 21529781; PMCID: PMC3116022.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimals
    207. The attentional blink in schizophrenia: isolating the perception/attention interface. J Psychiatr Res. 2011 Oct; 45(10):1346-51. Mathis KI, Wynn JK, Breitmeyer B, Nuechterlein KH, Green MF. PMID: 21550051; PMCID: PMC3183173.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    208. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry. 2011 Sep; 168(9):930-46. Greenwood TA, Lazzeroni LC, Murray SS, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Gur RE, Gur RC, Hardiman G, Kelsoe JR, Leonard S, Light GA, Nuechterlein KH, Olincy A, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Freedman R, Braff DL. PMID: 21498463; PMCID: PMC3751972.
      View in: PubMed   Mentions: 135     Fields:    Translation:Humans
    209. Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients. Schizophr Bull. 2012 Jun; 38(4):865-72. Horan WP, Green MF, DeGroot M, Fiske A, Hellemann G, Kee K, Kern RS, Lee J, Sergi MJ, Subotnik KL, Sugar CA, Ventura J, Nuechterlein KH. PMID: 21382881; PMCID: PMC3406537.
      View in: PubMed   Mentions: 103     Fields:    Translation:Humans
    210. Efficacy and specificity of social cognitive skills training for outpatients with psychotic disorders. J Psychiatr Res. 2011 Aug; 45(8):1113-22. Horan WP, Kern RS, Tripp C, Hellemann G, Wynn JK, Bell M, Marder SR, Green MF. PMID: 21377168; PMCID: PMC4064828.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    211. Bifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophrenia. Psychol Assess. 2011 Mar; 23(1):245-61. Reise SP, Ventura J, Keefe RS, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder R. PMID: 21381848; PMCID: PMC3183749.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    212. Social cognition in schizophrenia, Part 1: performance across phase of illness. Schizophr Bull. 2012 Jun; 38(4):854-64. Green MF, Bearden CE, Cannon TD, Fiske AP, Hellemann GS, Horan WP, Kee K, Kern RS, Lee J, Sergi MJ, Subotnik KL, Sugar CA, Ventura J, Yee CM, Nuechterlein KH. PMID: 21345917; PMCID: PMC3406534.
      View in: PubMed   Mentions: 138     Fields:    Translation:Humans
    213. Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia. Am J Psychiatry. 2011 Apr; 168(4):400-7. Green MF, Schooler NR, Kern RS, Frese FJ, Granberry W, Harvey PD, Karson CN, Peters N, Stewart M, Seidman LJ, Sonnenberg J, Stone WS, Walling D, Stover E, Marder SR. PMID: 21285142.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    214. Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res. 2011 May; 128(1-3):102-10. Stone WS, Giuliano AJ, Tsuang MT, Braff DL, Cadenhead KS, Calkins ME, Dobie DJ, Faraone SV, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Olincy A, Radant AD, Roe AH, Schork NJ, Siever LJ, Silverman JM, Swerdlow NR, Thomas AR, Tsuang DW, Turetsky BI, Seidman LJ. PMID: 21288694; PMCID: PMC6819951.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    215. Theory of mind in schizophrenia: exploring neural mechanisms of belief attribution. Soc Neurosci. 2011; 6(5-6):569-81. Lee J, Quintana J, Nori P, Green MF. PMID: 22050432; PMCID: PMC3928144.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    216. Altered dynamic coupling of lateral occipital complex during visual perception in schizophrenia. Neuroimage. 2011 Apr 01; 55(3):1219-26. Harvey PO, Lee J, Cohen MS, Engel SA, Glahn DC, Nuechterlein KH, Wynn JK, Green MF. PMID: 21194569; PMCID: PMC3049854.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    217. The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. Schizophr Res. 2011 Mar; 126(1-3):124-31. Kern RS, Gold JM, Dickinson D, Green MF, Nuechterlein KH, Baade LE, Keefe RS, Mesholam-Gately RI, Seidman LJ, Lee C, Sugar CA, Marder SR. PMID: 21159492; PMCID: PMC3050090.
      View in: PubMed   Mentions: 103     Fields:    Translation:Humans
    218. Do patients with schizophrenia benefit from a self-referential memory bias? Schizophr Res. 2011 Apr; 127(1-3):171-7. Harvey PO, Lee J, Horan WP, Ochsner K, Green MF. PMID: 21147520; PMCID: PMC3050992.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    219. A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biol Psychiatry. 2011 Mar 01; 69(5):442-9. Buchanan RW, Keefe RS, Lieberman JA, Barch DM, Csernansky JG, Goff DC, Gold JM, Green MF, Jarskog LF, Javitt DC, Kimhy D, Kraus MS, McEvoy JP, Mesholam-Gately RI, Seidman LJ, Ball MP, McMahon RP, Kern RS, Robinson J, Marder SR. PMID: 21145041; PMCID: PMC3058394.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    220. Social cognition in psychosis: multidimensional structure, clinical correlates, and relationship with functional outcome. Schizophr Res. 2011 Feb; 125(2-3):143-51. Mancuso F, Horan WP, Kern RS, Green MF. PMID: 21112743; PMCID: PMC3073542.
      View in: PubMed   Mentions: 95     Fields:    Translation:Humans
    221. Visual masking by object substitution in schizophrenia. Psychol Med. 2011 Jul; 41(7):1489-96. Green MF, Wynn JK, Breitmeyer B, Mathis KI, Nuechterlein KH. PMID: 21078224; PMCID: PMC3266659.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    222. The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition. Schizophr Res. 2010 Aug; 121(1-3):24-31. Ventura J, Reise SP, Keefe RS, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder RM. PMID: 20542412; PMCID: PMC3184638.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    223. Impaired anticipatory event-related potentials in schizophrenia. Int J Psychophysiol. 2010 Aug; 77(2):141-9. Wynn JK, Horan WP, Kring AM, Simons RF, Green MF. PMID: 20573584; PMCID: PMC2907238.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    224. Regional brain activity during early visual perception in unaffected siblings of schizophrenia patients. Biol Psychiatry. 2010 Jul 01; 68(1):78-85. Lee J, Cohen MS, Engel SA, Glahn D, Nuechterlein KH, Wynn JK, Green MF. PMID: 20494338; PMCID: PMC2921272.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    225. The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later? Schizophr Bull. 2011 Nov; 37(6):1209-17. Buchanan RW, Keefe RS, Umbricht D, Green MF, Laughren T, Marder SR. PMID: 20410237; PMCID: PMC3196938.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    226. Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophr Res. 2010 Jun; 119(1-3):175-82. Olincy A, Braff DL, Adler LE, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Wagner BD, Freedman R. PMID: 20382002; PMCID: PMC3688282.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    227. Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology. 2010 Sep; 47(5):846-56. Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Meichle SP, Millard SP, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang MT, Turetsky BI, Tsuang DW. PMID: 20374545; PMCID: PMC4176871.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    228. How do schizophrenia patients use visual information to decode facial emotion? Schizophr Bull. 2011 Sep; 37(5):1001-8. Lee J, Gosselin F, Wynn JK, Green MF. PMID: 20156852; PMCID: PMC3160215.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    229. Electrophysiological correlates of emotional responding in schizophrenia. J Abnorm Psychol. 2010 Feb; 119(1):18-30. Horan WP, Wynn JK, Kring AM, Simons RF, Green MF. PMID: 20141239; PMCID: PMC2852318.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    230. Integrity of emotional and motivational states during the prodromal, first-episode, and chronic phases of schizophrenia. J Abnorm Psychol. 2010 Feb; 119(1):71-82. Yee CM, Mathis KI, Sun JC, Sholty GL, Lang PJ, Bachman P, Williams TJ, Bearden CE, Cannon TD, Green MF, Subotnik KL, Ventura J, Nuechterlein KH. PMID: 20141244; PMCID: PMC2853376.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    231. Mismatch negativity, social cognition, and functioning in schizophrenia patients. Biol Psychiatry. 2010 May 15; 67(10):940-7. Wynn JK, Sugar C, Horan WP, Kern R, Green MF. PMID: 20074704; PMCID: PMC2862843.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    232. Further support for the role of dysfunctional attitudes in models of real-world functioning in schizophrenia. J Psychiatr Res. 2010 Jun; 44(8):499-505. Horan WP, Rassovsky Y, Kern RS, Lee J, Wynn JK, Green MF. PMID: 20006849; PMCID: PMC3414437.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    233. Functional neuroanatomy of visual masking deficits in schizophrenia. Arch Gen Psychiatry. 2009 Dec; 66(12):1295-303. Green MF, Lee J, Cohen MS, Engel SA, Korb AS, Nuechterlein KH, Wynn JK, Glahn DC. PMID: 19996034; PMCID: PMC2907419.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    234. Cognitive training for divergent thinking in schizophrenia: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13; 33(8):1533-6. Nemoto T, Yamazawa R, Kobayashi H, Fujita N, Chino B, Fujii C, Kashima H, Rassovsky Y, Green MF, Mizuno M. PMID: 19733608.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    235. The challenges of ecological validity in the measurement of social perception in schizophrenia. J Nerv Ment Dis. 2009 Sep; 197(9):700-2. Vaskinn A, Sergi MJ, Green MF. PMID: 19752651.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    236. New possibilities in cognition enhancement for schizophrenia. Am J Psychiatry. 2009 Jul; 166(7):749-52. Green MF. PMID: 19570935.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    237. Development of a measure of relationship perception in schizophrenia. Psychiatry Res. 2009 Mar 31; 166(1):54-62. Sergi MJ, Fiske AP, Horan WP, Kern RS, Kee KS, Subotnik KL, Nuechterlein KH, Green MF. PMID: 19193447.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    238. Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals. J Neuropsychiatry Clin Neurosci. 2009; 21(3):254-8. Kalechstein AD, De la Garza R, Newton TF, Green MF, Cook IA, Leuchter AF. PMID: 19776303; PMCID: PMC3350803.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    239. Perception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS. Schizophr Bull. 2009 Jan; 35(1):163-81. Green MF, Butler PD, Chen Y, Geyer MA, Silverstein S, Wynn JK, Yoon JH, Zemon V. PMID: 19023123; PMCID: PMC2635893.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansAnimals
    240. Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting. Schizophr Bull. 2009 Jan; 35(1):109-14. Barch DM, Carter CS, Arnsten A, Buchanan RW, Cohen JD, Geyer M, Green MF, Krystal JH, Nuechterlein K, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T, Heinssen R. PMID: 19023126; PMCID: PMC2643950.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    241. Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function. Schizophr Res. 2009 Feb; 107(2-3):275-85. Kleinman L, Lieberman J, Dube S, Mohs R, Zhao Y, Kinon B, Carpenter W, Harvey PD, Green MF, Keefe RS, Frank L, Bowman L, Revicki DA. PMID: 19013769.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    242. CMINDS does not have identical tests to the CATIE and MATRICS batteries. Commentary on O'Halloran et al. Schizophr Res. 2009 Feb; 107(2-3):327-9; author reply 330-1. Kern RS, Green MF, Nuechterlein KH, Keefe RS. PMID: 19013770.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    243. Increased extent of object-selective cortex in schizophrenia. Psychiatry Res. 2008 Nov 30; 164(2):97-105. Wynn JK, Green MF, Engel S, Korb A, Lee J, Glahn D, Nuechterlein KH, Cohen MS. PMID: 18938066; PMCID: PMC2683746.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    244. Social cognitive skills training in schizophrenia: an initial efficacy study of stabilized outpatients. Schizophr Res. 2009 Jan; 107(1):47-54. Horan WP, Kern RS, Shokat-Fadai K, Sergi MJ, Wynn JK, Green MF. PMID: 18930378; PMCID: PMC2653055.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    245. Emotional intelligence in schizophrenia. Schizophr Res. 2009 Jan; 107(1):61-8. Kee KS, Horan WP, Salovey P, Kern RS, Sergi MJ, Fiske AP, Lee J, Subotnik KL, Nuechterlein K, Sugar CA, Green MF. PMID: 18805674.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    246. Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study. Schizophr Res. 2008 Dec; 106(2-3):320-7. Goff DC, Cather C, Gottlieb JD, Evins AE, Walsh J, Raeke L, Otto MW, Schoenfeld D, Green MF. PMID: 18799288; PMCID: PMC2628436.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    247. Impaired implicit learning in schizophrenia. Neuropsychology. 2008 Sep; 22(5):606-17. Horan WP, Green MF, Knowlton BJ, Wynn JK, Mintz J, Nuechterlein KH. PMID: 18763880; PMCID: PMC2548320.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    248. Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biol Psychiatry. 2008 Dec 15; 64(12):1051-9. Turetsky BI, Greenwood TA, Olincy A, Radant AD, Braff DL, Cadenhead KS, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Calkins ME. PMID: 18701089; PMCID: PMC2653714.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    249. Affective traits in schizophrenia and schizotypy. Schizophr Bull. 2008 Sep; 34(5):856-74. Horan WP, Blanchard JJ, Clark LA, Green MF. PMID: 18667393; PMCID: PMC2632479.
      View in: PubMed   Mentions: 94     Fields:    Translation:Humans
    250. Using event related potentials to explore stages of facial affect recognition deficits in schizophrenia. Schizophr Bull. 2008 Jul; 34(4):679-87. Wynn JK, Lee J, Horan WP, Green MF. PMID: 18499704; PMCID: PMC2632462.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    251. Social cognition in schizophrenia. Schizophr Bull. 2008 Jul; 34(4):670-2. Green MF, Leitman DI. PMID: 18495642; PMCID: PMC2632454.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    252. Stability of visual masking performance in recent-onset schizophrenia: an 18-month longitudinal study. Schizophr Res. 2008 Aug; 103(1-3):266-74. Lee J, Nuechterlein KH, Subotnik KL, Sugar CA, Ventura J, Gretchen-Doorly D, Kelly K, Green MF. PMID: 18450427; PMCID: PMC2859819.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    253. Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res. 2008 Aug; 103(1-3):218-28. Horan WP, Braff DL, Nuechterlein KH, Sugar CA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Olincy A, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Green MF. PMID: 18406578; PMCID: PMC2529172.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    254. Errorless learning for training individuals with schizophrenia at a community mental health setting providing work experience. Schizophr Bull. 2009 Jul; 35(4):807-15. Kern RS, Liberman RP, Becker DR, Drake RE, Sugar CA, Green MF. PMID: 18326529; PMCID: PMC2696371.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    255. Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophr Bull. 2008 Nov; 34(6):1211-20. Green MF, Penn DL, Bentall R, Carpenter WT, Gaebel W, Gur RC, Kring AM, Park S, Silverstein SM, Heinssen R. PMID: 18184635; PMCID: PMC2632490.
      View in: PubMed   Mentions: 262     Fields:    Translation:Humans
    256. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. Am J Psychiatry. 2008 Feb; 165(2):221-8. Green MF, Nuechterlein KH, Kern RS, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Seidman LJ, Stover E, Marder SR. PMID: 18172017.
      View in: PubMed   Mentions: 105     Fields:    Translation:Humans
    257. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry. 2008 Feb; 165(2):214-20. Kern RS, Nuechterlein KH, Green MF, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Mintz J, Seidman LJ, Stover E, Marder SR. PMID: 18172018.
      View in: PubMed   Mentions: 281     Fields:    Translation:Humans
    258. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008 Feb; 165(2):203-13. Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, Seidman LJ, Stover E, Weinberger DR, Young AS, Zalcman S, Marder SR. PMID: 18172019.
      View in: PubMed   Mentions: 925     Fields:    Translation:Humans
    259. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry. 2007 Nov; 64(11):1242-50. Greenwood TA, Braff DL, Light GA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Mintz J, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Schork NJ. PMID: 17984393; PMCID: PMC10588564.
      View in: PubMed   Mentions: 186     Fields:    Translation:Humans
    260. Remember and know judgments during recognition in chronic schizophrenia. Schizophr Res. 2008 Mar; 100(1-3):181-90. van Erp TG, Lesh TA, Knowlton BJ, Bearden CE, Hardt M, Karlsgodt KH, Shirinyan D, Rao V, Green MF, Subotnik KL, Nuechterlein K, Cannon TD. PMID: 17964760; PMCID: PMC2517628.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    261. Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol. Am J Psychiatry. 2007 Oct; 164(10):1585-92. Sergi MJ, Green MF, Widmark C, Reist C, Erhart S, Braff DL, Kee KS, Marder SR, Mintz J. PMID: 17898351.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    262. A relationship between neurocognitive impairment and functional impairment in bipolar disorder: a pilot study. Psychiatry Res. 2008 Jan 15; 157(1-3):289-93. Altshuler LL, Bearden CE, Green MF, van Gorp W, Mintz J. PMID: 17868903.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    263. Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial. Schizophr Res. 2007 Sep; 95(1-3):134-42. Wynn JK, Green MF, Sprock J, Light GA, Widmark C, Reist C, Erhart S, Marder SR, Mintz J, Braff DL. PMID: 17662577; PMCID: PMC2716219.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    264. Cognition, drug treatment, and functional outcome in schizophrenia: a tale of two transitions. Am J Psychiatry. 2007 Jul; 164(7):992-4. Green MF. PMID: 17606645.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    265. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry. 2007 Jun; 64(6):633-47. Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, Hsiao JK, Lieberman JA, CATIE Investigators, Neurocognitive Working Group. PMID: 17548746.
      View in: PubMed   Mentions: 358     Fields:    Translation:Humans
    266. A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology. 2008 Feb; 33(3):465-72. Goff DC, Lamberti JS, Leon AC, Green MF, Miller AL, Patel J, Manschreck T, Freudenreich O, Johnson SA. PMID: 17487227; PMCID: PMC3098468.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    267. Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res. 2007 Jul; 93(1-3):253-60. Gard DE, Kring AM, Gard MG, Horan WP, Green MF. PMID: 17490858; PMCID: PMC1986826.
      View in: PubMed   Mentions: 283     Fields:    Translation:Humans
    268. Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res. 2007 May; 92(1-3):237-51. Swerdlow NR, Sprock J, Light GA, Cadenhead K, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Mintz J, Olincy A, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 17346930; PMCID: PMC2039885.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    269. How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia. Schizophr Bull. 2007 Sep; 33(5):1247-56. Brekke JS, Hoe M, Long J, Green MF. PMID: 17255120; PMCID: PMC2632359.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    270. Stimulating the development of drug treatments to improve cognition in schizophrenia. Annu Rev Clin Psychol. 2007; 3:159-80. Green MF. PMID: 17716052.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    271. Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophr Res. 2007 Feb; 90(1-3):316-24. Sergi MJ, Rassovsky Y, Widmark C, Reist C, Erhart S, Braff DL, Marder SR, Green MF. PMID: 17141477.
      View in: PubMed   Mentions: 113     Fields:    Translation:Humans
    272. The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull. 2007 Jan; 33(1):33-48. Calkins ME, Dobie DJ, Cadenhead KS, Olincy A, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 17035358; PMCID: PMC2632302.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    273. Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res. 2007 Jan; 89(1-3):320-9. Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Light GA, Meichle SP, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang MT, Turetsky BI, Tsuang DW. PMID: 17023145.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    274. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry. 2006 Oct; 67(10):e12. Green MF. PMID: 17107235.
      View in: PubMed   Mentions: 126     Fields:    Translation:Humans
    275. Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop. Schizophr Bull. 2007 May; 33(3):805-22. Bellack AS, Green MF, Cook JA, Fenton W, Harvey PD, Heaton RK, Laughren T, Leon AC, Mayo DJ, Patrick DL, Patterson TL, Rose A, Stover E, Wykes T. PMID: 16931542; PMCID: PMC2526156.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    276. Exploring the short term visual store in schizophrenia using the attentional blink. J Psychiatr Res. 2006 Oct; 40(7):599-605. Wynn JK, Breitmeyer B, Nuechterlein KH, Green MF. PMID: 16890242.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    277. Does anhedonia in schizophrenia reflect faulty memory for subjectively experienced emotions? J Abnorm Psychol. 2006 Aug; 115(3):496-508. Horan WP, Green MF, Kring AM, Nuechterlein KH. PMID: 16866590.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    278. An analysis of categorical perception of facial emotion in schizophrenia. Schizophr Res. 2006 Oct; 87(1-3):228-37. Kee KS, Horan WP, Wynn JK, Mintz J, Green MF. PMID: 16859896.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    279. The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine. Psychopharmacology (Berl). 2006 Aug; 187(3):312-20. Kern RS, Green MF, Cornblatt BA, Owen JR, McQuade RD, Carson WH, Ali M, Marcus R. PMID: 16810506.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    280. The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements. Psychopharmacology (Berl). 2006 Aug; 187(3):356-63. Harvey PD, Green MF, Bowie C, Loebel A. PMID: 16783539.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    281. Dissociable mechanisms for memory impairment in bipolar disorder and schizophrenia. Psychol Med. 2006 Aug; 36(8):1085-95. Glahn DC, Barrett J, Bearden CE, Mintz J, Green MF, Serap Monkul E, Najt P, Soares JC, Velligan DI. PMID: 16734948.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    282. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology. 2006 Sep; 31(9):2033-46. Keefe RS, Bilder RM, Harvey PD, Davis SM, Palmer BW, Gold JM, Meltzer HY, Green MF, Miller DD, Canive JM, Adler LW, Manschreck TC, Swartz M, Rosenheck R, Perkins DO, Walker TM, Stroup TS, McEvoy JP, Lieberman JA. PMID: 16641947.
      View in: PubMed   Mentions: 148     Fields:    Translation:HumansCTClinical Trials
    283. Neurocognitive and social cognitive correlates of formal thought disorder in schizophrenia patients. Schizophr Res. 2006 Jul; 85(1-3):84-95. Subotnik KL, Nuechterlein KH, Green MF, Horan WP, Nienow TM, Ventura J, Nguyen AT. PMID: 16624529.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    284. Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr Res. 2006 May; 84(1):100-11. Niendam TA, Bearden CE, Johnson JK, McKinley M, Loewy R, O'Brien M, Nuechterlein KH, Green MF, Cannon TD. PMID: 16563699.
      View in: PubMed   Mentions: 93     Fields:    Translation:Humans
    285. Quantitative EEG and low resolution electromagnetic tomography (LORETA) imaging of patients with persistent auditory hallucinations. Schizophr Res. 2006 Apr; 83(2-3):111-9. Lee SH, Wynn JK, Green MF, Kim H, Lee KJ, Nam M, Park JK, Chung YC. PMID: 16524699.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    286. Social perception as a mediator of the influence of early visual processing on functional status in schizophrenia. Am J Psychiatry. 2006 Mar; 163(3):448-54. Sergi MJ, Rassovsky Y, Nuechterlein KH, Green MF. PMID: 16513866.
      View in: PubMed   Mentions: 120     Fields:    Translation:Humans
    287. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry. 2006; 67 Suppl 9:3-8; discussion 36-42. Green MF. PMID: 16965182.
      View in: PubMed   Mentions: 176     Fields:    Translation:Humans
    288. Event-related gamma activity in schizophrenia patients during a visual backward-masking task. Am J Psychiatry. 2005 Dec; 162(12):2330-6. Wynn JK, Light GA, Breitmeyer B, Nuechterlein KH, Green MF. PMID: 16330598; PMCID: PMC9973373.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    289. Visual processing in schizophrenia: Structural equation modeling of visual masking performance. Schizophr Res. 2005 Oct 15; 78(2-3):251-60. Rassovsky Y, Green MF, Nuechterlein KH, Breitmeyer BG, Mintz J. PMID: 15975768.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    290. Cross-ethnic differences in perception of emotion in schizophrenia. Schizophr Res. 2005 Sep 15; 77(2-3):289-98. Brekke JS, Nakagami E, Kee KS, Green MF. PMID: 15923111.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    291. Forward and backward visual masking in unaffected siblings of schizophrenic patients. Biol Psychiatry. 2006 Mar 01; 59(5):446-51. Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. PMID: 16139818.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    292. Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. J Clin Psychiatry. 2005 Sep; 66(9):1184-90. Evins AE, Deckersbach T, Cather C, Freudenreich O, Culhane MA, Henderson DC, Green MF, Schoenfeld DA, Rigotti NA, Goff DC. PMID: 16187778.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    293. Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophr Bull. 2005 Oct; 31(4):882-7. Green MF, Olivier B, Crawley JN, Penn DL, Silverstein S. PMID: 16135561.
      View in: PubMed   Mentions: 112     Fields:    Translation:HumansAnimals
    294. Biosocial pathways to functional outcome in schizophrenia. Schizophr Res. 2005 Dec 15; 80(2-3):213-25. Brekke J, Kay DD, Lee KS, Green MF. PMID: 16137859.
      View in: PubMed   Mentions: 144     Fields:    Translation:Humans
    295. Modulation of attention during visual masking in schizophrenia. Am J Psychiatry. 2005 Aug; 162(8):1533-5. Rassovsky Y, Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. PMID: 16055778.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    296. The effects of clozapine and risperidone on spatial working memory in schizophrenia. Am J Psychiatry. 2005 May; 162(5):1013-6. McGurk SR, Carter C, Goldman R, Green MF, Marder SR, Xie H, Schooler NR, Kane JM. PMID: 15863811.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    297. The FOCIS international survey on psychiatrists' opinions on cognition in schizophrenia. Schizophr Res. 2005 May 01; 74(2-3):253-61. Green MF, Barnes TR, Danion JM, Gallhofer B, Meltzer HY, Pantelis C. PMID: 15722004.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    298. Extensions of errorless learning for social problem-solving deficits in schizophrenia. Am J Psychiatry. 2005 Mar; 162(3):513-9. Kern RS, Green MF, Mitchell S, Kopelowicz A, Mintz J, Liberman RP. PMID: 15741468.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    299. Sensorimotor gating, orienting and social perception in schizophrenia. Schizophr Res. 2005 Mar 01; 73(2-3):319-25. Wynn JK, Sergi MJ, Dawson ME, Schell AM, Green MF. PMID: 15653277.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    300. Learning potential and the prediction of work skill acquisition in schizophrenia. Schizophr Bull. 2005 Jan; 31(1):67-72. Sergi MJ, Kern RS, Mintz J, Green MF. PMID: 15888426.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    301. A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull. 2005 Jan; 31(1):5-19. Buchanan RW, Davis M, Goff D, Green MF, Keefe RS, Leon AC, Nuechterlein KH, Laughren T, Levin R, Stover E, Fenton W, Marder SR. PMID: 15888422.
      View in: PubMed   Mentions: 179     Fields:    Translation:Humans
    302. Regional brain activity associated with visual backward masking. J Cogn Neurosci. 2005 Jan; 17(1):13-23. Green MF, Glahn D, Engel SA, Nuechterlein KH, Sabb F, Strojwas M, Cohen MS. PMID: 15701236.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    303. Identification of separable cognitive factors in schizophrenia. Schizophr Res. 2004 Dec 15; 72(1):29-39. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. PMID: 15531405.
      View in: PubMed   Mentions: 414     Fields:    Translation:Humans
    304. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res. 2004 Dec 15; 72(1):41-51. Green MF, Kern RS, Heaton RK. PMID: 15531406.
      View in: PubMed   Mentions: 476     Fields:    Translation:Humans
    305. NIMH-MATRICS survey on assessment of neurocognition in schizophrenia. Schizophr Res. 2004 Dec 15; 72(1):11-9. Kern RS, Green MF, Nuechterlein KH, Deng BH. PMID: 15531403.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    306. The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr Res. 2004 Dec 15; 72(1):1-3. Green MF, Nuechterlein KH. PMID: 15531401.
      View in: PubMed   Mentions: 86     Fields:    Translation:Humans
    307. Paracontrast and metacontrast in schizophrenia: clarifying the mechanism for visual masking deficits. Schizophr Res. 2004 Dec 01; 71(2-3):485-92. Rassovsky Y, Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. PMID: 15474919.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    308. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biol Psychiatry. 2004 Oct 15; 56(8):560-9. Altshuler LL, Ventura J, van Gorp WG, Green MF, Theberge DC, Mintz J. PMID: 15476685.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    309. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry. 2004 Sep 01; 56(5):301-7. Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RS, Kern RS, Kraemer H, Stover E, Weinberger DR, Zalcman S, Marder SR. PMID: 15336511.
      View in: PubMed   Mentions: 290     Fields:    Translation:Humans
    310. Self-efficacy and neurocognition may be related to coping responses in recent-onset schizophrenia. Schizophr Res. 2004 Aug 01; 69(2-3):343-52. Ventura J, Nuechterlein KH, Subotnik KL, Green MF, Gitlin MJ. PMID: 15469206.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    311. The timing of negative symptom exacerbations in relationship to positive symptom exacerbations in the early course of schizophrenia. Schizophr Res. 2004 Aug 01; 69(2-3):333-42. Ventura J, Nuechterlein KH, Green MF, Horan WP, Subotnik KL, Mintz J. PMID: 15469205.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    312. Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia. Schizophr Res. 2004 Jun 01; 68(2-3):225-33. McGurk SR, Green MF, Wirshing WC, Wirshing DA, Marder SR, Mintz J, Kern R. PMID: 15099605.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    313. Review of cognition and brain structure in schizophrenia: profiles, longitudinal course, and effects of treatment. Psychiatr Clin North Am. 2004 Mar; 27(1):1-18, vii. Flashman LA, Green MF. PMID: 15062627.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    314. Prepulse facilitation and prepulse inhibition in schizophrenia patients and their unaffected siblings. Biol Psychiatry. 2004 Mar 01; 55(5):518-23. Wynn JK, Dawson ME, Schell AM, McGee M, Salveson D, Green MF. PMID: 15023580.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    315. Do the siblings of schizophrenia patients demonstrate affect perception deficits? Schizophr Res. 2004 Mar 01; 67(1):87-94. Kee KS, Horan WP, Mintz J, Green MF. PMID: 14741328.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    316. Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness. J Clin Psychiatry. 2004 Mar; 65(3):361-72. Harvey PD, Green MF, Keefe RS, Velligan DI. PMID: 15096076.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    317. Dynamic testing in schizophrenia: does training change the construct validity of a test? Schizophr Bull. 2004; 30(4):703-11. Wiedl KH, Schöttke H, Green MF, Nuechterlein KH. PMID: 15954185.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    318. Lateralized lexical decision in schizophrenia: hemispheric specialization and interhemispheric lexicality priming. J Abnorm Psychol. 2003 Nov; 112(4):623-32. Narr KL, Green MF, Capetillo-Cunliffe L, Toga AW, Zaidel E. PMID: 14674874.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    319. Neuroanatomical correlates of formal thought disorder in schizophrenia. Cogn Neuropsychiatry. 2003 May; 8(2):81-8. Subotnik KL, Bartzokis G, Green MF, Nuechterlein KH. PMID: 16571552.
      View in: PubMed   Mentions: 8     Fields:    
    320. Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study. Psychopharmacology (Berl). 2003 Sep; 169(3-4):404-11. Harvey PD, Green MF, McGurk SR, Meltzer HY. PMID: 12590356.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    321. Is emotion processing a predictor of functional outcome in schizophrenia? Schizophr Bull. 2003; 29(3):487-97. Kee KS, Green MF, Mintz J, Brekke JS. PMID: 14609242.
      View in: PubMed   Mentions: 98     Fields:    Translation:Humans
    322. Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. Schizophr Bull. 2003; 29(1):45-55. Keefe RS, Mohs RC, Bilder RM, Harvey PD, Green MF, Meltzer HY, Gold JM, Sano M. PMID: 12908660.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    323. Schizophrenia and schizotypal personality: a tribute to Peter H. Venables. Schizophr Res. 2002 Mar 01; 54(1-2):1-5. Raine A, Green MF. PMID: 11853972.
      View in: PubMed   Mentions: 1     Fields:    
    324. Nonverbal social perception and symptomatology in schizophrenia. Schizophr Res. 2002 Jan 01; 53(1-2):83-91. Toomey R, Schuldberg D, Corrigan P, Green MF. PMID: 11728841.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    325. Backward masking in unmedicated schizophrenic patients in psychotic remission: possible reflection of aberrant cortical oscillation. Am J Psychiatry. 1999 Sep; 156(9):1367-73. Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. PMID: 10484946.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    326. Does risperidone improve verbal working memory in treatment-resistant schizophrenia? Am J Psychiatry. 1997 Jun; 154(6):799-804. Green MF, Marshall BD, Wirshing WC, Ames D, Marder SR, McGurk S, Kern RS, Mintz J. PMID: 9167507.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCTClinical Trials
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Michael's Networks
    Concepts (503)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (57)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California